Ventricular assist device

Information

  • Patent Grant
  • 11839754
  • Patent Number
    11,839,754
  • Date Filed
    Thursday, February 14, 2019
    5 years ago
  • Date Issued
    Tuesday, December 12, 2023
    a year ago
  • CPC
  • Field of Search
    • CPC
    • A61M1/122
    • A61M1/1086
    • A61M1/125
    • A61M2205/3334
    • A61M1/1031
    • A61M2205/3327
    • A61M2205/3365
    • A61M25/00
    • A61M2205/04
    • A61M5/14276
    • A61N1/05
  • International Classifications
    • A61M1/00
    • A61M60/414
    • A61M60/148
    • A61M60/17
    • A61M60/237
    • A61M60/139
    • A61M60/825
    • A61M60/806
Abstract
Apparatus and methods are described including a tube configured to traverse a subject's aortic valve. A frame is disposed within a portion of the tube, and a plurality of winged projections are coupled to the frame. An impeller is disposed inside the tube, the impeller including proximal and distal bushings, a helical elongate element, and a spring disposed inside of the helical elongate element, the spring defining a lumen therethrough. A film of material is supported between the helical elongate element and the spring. A rigid shaft extends from the proximal bushing to the distal bushing via the lumen defined by the spring. The impeller is rotated, such as to pump blood from the subject's left ventricle to the subject's aorta. Other applications are also described.
Description
FIELD OF EMBODIMENTS OF THE INVENTION

Some applications of the present invention generally relate to medical apparatus. Specifically, some applications of the present invention relate to a ventricular assist device and methods of use thereof.


BACKGROUND

Ventricular assist devices are used to assist cardiac circulation, for patients suffering from a failing heart. Most commonly a left-ventricular assist device is applied to a defective heart, in order to assist left-ventricular functioning. In some cases, a right-ventricular assist device is used, in order to assist right-ventricular functioning.


SUMMARY OF EMBODIMENTS

In accordance with some applications of the present invention, an impeller includes a helical elongate element, a spring that is disposed inside of, and coaxially with, the helical elongate element, and a film of material supported between the helical elongate element and the spring. For some applications, the impeller comprises a portion of a ventricular assist device configured to assist ventricular functioning of a subject, e.g., a left-ventricular assist device is configured to assist left ventricular functioning of a subject. The ventricular assist device typically includes an elongate tube configured to traverse the subject's aortic valve, such that a proximal end of the tube is disposed within the subject's aorta and a distal end of the tube is disposed within the subject's left ventricle. The elongate tube includes a frame formed from a self-expandable shape-memory alloy, and a blood impermeable material that is disposed upon the frame. The ventricular assist device includes a pump, which typically includes the impeller and a cage disposed around the impeller. The impeller is typically configured to pump blood out of the subject's left ventricle and into the subject's aorta, by rotating. Typically, the impeller also impedes backflow of blood across the aortic valve, from the aorta into the left ventricle.


For some applications, the cage is integrally formed with the elongate tube such that the cage is disposed within the frame of the elongate tube at the proximal end of the elongate tube. The pump is thereby disposed within a proximal portion of the elongate tube, and a longitudinal axis of the pump is thereby aligned with a longitudinal axis of the elongate tube. Alternatively, the cage is not integrally formed with the elongate tube.


There is therefore provided, in accordance with some applications of the present invention, apparatus including:

    • an impeller including:
      • at least one helical elongate element;
      • a spring, the spring being disposed inside of, and coaxially with, the helical elongate element; and
      • a film of material supported between the helical elongate element and the spring.


In some applications, the impeller includes a plurality of helical elongate elements, and the film of material is supported between the plurality of helical elongate elements and the spring, such that the impeller defines a plurality of blades.


In some applications, when the impeller is disposed in a non-radially-constrained configuration, a pitch of the helical elongate element varies along a length of the helical elongate element.


In some applications, when the impeller is disposed in a non-radially-constrained configuration, a pitch of the helical elongate element is greater than 1 mm.


In some applications, when the impeller is disposed in a non-radially-constrained configuration, a pitch of the helical elongate element is less than 20 mm.


In some applications, the impeller is configured to be placed inside a blood vessel of a subject and to pump blood through the subject's blood vessel by the impeller rotating.


In some applications, the impeller is configured to be placed in an aorta of a subject and to pump blood from a left ventricle of the subject, by the impeller rotating.


In some applications, the impeller is configured to be placed in a ventricle of a subject and to pump blood from the ventricle, by the impeller rotating.


In some applications, the impeller is configured to be placed in an aorta of a subject and to impede backflow of blood from the aorta into a left ventricle of the subject.


In some applications, the impeller is configured to be radially constrained by the helical elongate element and the spring being axially elongated, and in response to the axial elongation of the helical elongate element and the spring, the film is configured to change shape without the film of material breaking.


In some applications, the apparatus further includes:

    • an elongate tube configured to traverse an aortic valve of a subject, such that a proximal end of the tube is disposed within an aorta of the subject and a distal end of the tube is disposed within a left ventricle of the subject, the elongate tube including:
      • a frame formed from a shape-memory alloy; and
      • a blood impermeable material that is disposed upon the frame; and
    • a cage disposed around the impeller,
    • the elongate tube being configured to be disposed around the cage and the impeller, and the impeller being configured to pump blood from the left ventricle to the aorta, by rotating.


In some applications, the spring, when disposed in a non-radially-constrained configuration thereof, is configured by virtue of its rigidity, to stabilize the impeller with respect to the elongate tube, during rotation of the impeller, such that a gap between an outer edge of the impeller and an inner surface of the elongate tube is maintained.


In some applications:

    • the spring defines a lumen therethrough, and
    • the impeller further includes:
      • proximal and distal bushings; and
      • a rigid shaft configured to extend from the proximal bushing to the distal bushing via the lumen defined by the spring, the rigid shaft being configured to stabilize the impeller with respect to the elongate tube, during rotation of the impeller, such that a gap between an outer edge of the impeller and an inner surface of the elongate tube is maintained.


In some applications, the cage is integrally formed with the frame of the elongate tube such that the cage is disposed within the frame of the elongate tube at the proximal end of the elongate tube, the impeller thereby being disposed within a proximal portion of the elongate tube, and a longitudinal axis of the impeller thereby being aligned with a longitudinal axis of the elongate tube.


In some applications, a gap between an outer edge of the impeller and an inner surface of the elongate tube is less than 1 mm.


In some applications, the gap between the outer edge of the impeller and the inner surface of the elongate tube is less than 0.4 mm.


In some applications, the impeller is configured to be stabilized with respect to the elongate tube, such that, during rotation of the impeller, the gap between the impeller and the elongate tube is maintained.


In some applications, the cage is not integrally formed with the frame of the elongate tube.


In some applications, the apparatus further includes one or more support arms that are configured to extend from the cage to the frame of the elongate tube, and that are configured, during rotation of the impeller, to stabilize a distal end of the impeller with respect to the frame of the elongate tube, such that a gap between an outer edge of the impeller and an inner surface of the elongate tube is maintained.


In some applications, the support arms are configured to be slidable with respect to the frame of the elongate tube.


In some applications, the support arms are configured to be coupled to the frame of the elongate tube.


In some applications, the apparatus further includes a plurality of winged projections that are coupled to the elongate tube such that planes defined by the winged projections are parallel with a longitudinal axis of the elongate tube, the winged projections being configured to stabilize turbulent blood flow that is generated by rotation of the impeller, by directing blood flow along a direction of the longitudinal axis of the elongate tube.


In some applications, the elongate tube is configured to be inserted into a body of the subject transcatheterally, while in a radially-constrained configuration, and the winged projections are configured to become folded, when the elongate tube is in its radially-constrained configuration.


In some applications, the spring defines a lumen therethrough, and the impeller further includes:

    • proximal and distal bushings; and
    • a rigid shaft configured to extend from the proximal bushing to the distal bushing via the lumen defined by the spring.


In some applications, the rigid shaft is configured to maintain the proximal bushing and the distal bushing aligned with each other.


In some applications, the impeller is configured to be placed into a body of a subject, and subsequent to placement of the spring inside the subject's body, the rigid shaft is configured to be placed within the lumen defined by the spring.


In some applications, the impeller is configured to be placed into a body of a subject, and the rigid shaft is configured to be disposed within the lumen defined by the spring, during placement of the impeller into the subject's body,


In some applications, the impeller further includes proximal and distal bushings, and the spring, when disposed in a non-radially-constrained configuration thereof, is configured, by virtue of its rigidity, to maintain the proximal bushing and the distal bushing aligned with each other.


In some applications, the spring, when disposed in the non-radially-constrained configuration thereof, is configured such that there are substantially no gaps between windings of the spring and adjacent windings thereto.


There is further provided, in accordance with some applications of the present invention, a method including:

    • placing within a blood vessel of a subject an impeller, the impeller including:
      • at least one helical elongate element;
      • a spring, the spring being disposed inside of, and coaxially with, the helical elongate element; and
      • a film of material supported between the helical elongate element and the spring; pumping blood through the subject's blood vessel, using the impeller.


The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A and 1B are schematic illustrations of a ventricular assist device disposed in a subject's left ventricle, in accordance with some applications of the present invention;



FIG. 2 is a schematic illustration of a pump that includes an impeller and a cage, in accordance with some applications of the present invention;



FIG. 3 is a schematic illustration of a frame of an elongate tube of the ventricular assist device, and a cage of the impeller of the ventricular assist device, in accordance with some applications of the present invention;



FIGS. 4A and 4B are schematic illustrations of a ventricular assist device, in accordance with some additional applications of the present invention;



FIGS. 5A and 5B are schematic illustrations of respective cross-sectional views of an impeller of the ventricular assist device shown in FIGS. 4A and 4B in accordance with some applications of the present invention;



FIG. 5C is a schematic illustration of a cross-sectional view of the ventricular assist device shown in FIGS. 4A and 4B, in accordance with some applications of the present invention;



FIG. 5D is a schematic illustration of the impeller of the ventricular assist device shown in FIGS. 4A and 4B in a radially-constrained configuration, in accordance with some applications of the present invention;



FIGS. 6A and 6B are schematic illustrations of a stator of a ventricular assist device, in accordance with some applications of the present invention; and



FIGS. 7A, 7B, and 7C are schematic illustrations of a ventricular assist device that includes a centrifugal pump, in accordance with some applications of the present invention.





DETAILED DESCRIPTION OF EMBODIMENTS

Reference is now made to FIGS. 1A and 1B, which are schematic illustrations of a ventricular assist device 20 disposed in a subject's left ventricle 22, in accordance with some applications of the present invention. The ventricular assist device includes an elongate tube 24, which traverses an aortic valve 26 of the subject, such that a proximal end 28 of the elongate tube is disposed in an aorta 30 of the subject and a distal end 32 of the tube is disposed within left ventricle 22. The elongate tube typically includes a radially-expandable frame 34 formed from a self-expandable shape-memory alloy, such as nitinol, and a blood impermeable material 36 that is disposed upon the frame. For example, the blood impermeable material may include polyurethane, polyester, and/or silicone. Typically, the frame provides the elongate tube with rigidity, and the blood impermeable material provides the elongate tube with blood impermeability. Further typically, the shape memory alloy of the frame is shape set such the frame assumes its tubular shape in the absence of any forces being applied to the tube. Typically, device 20 is inserted into the left ventricle transcatheterally (e.g., via the brachial artery), while the tube is in a radially constrained state. Upon being released from the catheter, the tube automatically assumes it tubular shape, due to the frame expanding. A pump 40 is disposed within the elongate tube (e.g., within a proximal portion of the elongate tube, as shown), and is configured to pump blood through the elongate tube from the left ventricle into the aorta, to thereby assist left ventricular functioning.



FIG. 2 is a schematic illustration of pump 40, in accordance with some applications of the present invention. Pump 40 typically includes a radially-expandable impeller 42 disposed inside a radially-expandable cage 44. Typically, pump 40 is inserted into the left ventricle transcatheterally, while the impeller and the cage are in radially constrained configurations. The impeller and the cage typically include a shape memory alloy (such as nitinol), which is shape set such that the impeller and the cage assume non-radially-constrained (i.e., radially-expanded) configurations thereof in the absence of any radially-constraining force acting upon the impeller and the cage. Thus, typically, the cage and the impeller radially expand upon being released from the distal end of the catheter via which they are inserted. For some applications, an engagement mechanism engages the impeller and the cage with respect to one another, such that in response to the cage becoming radially constrained the impeller becomes radially constrained, e.g., in accordance with apparatus and methods described in described in WO 14/141284 to Schwammenthal, which is incorporated herein by reference. In general, pump 40 is generally similar to the blood pumps described in WO 14/141284 to Schwammenthal, WO 15/177793 to Schwammenthal, and/or WO 16/185473 to Schwammenthal, all of which are incorporated herein by reference. Typically, pump 40 pumps blood through the elongate tube from the left ventricle into the aorta, by the impeller rotating. For some applications, a rotating cable 46 (FIG. 1B) rotates the impeller. Typically, the rotating cable is rotated by a motor (not shown) which is disposed outside the subject's body, or inside the subject's body.


For some applications, pump 40 is disposed at a proximal end of the elongate tube, such that the pump is disposed within the aorta. For some applications, the pump is disposed at the distal end of the elongate tube, such that the pump is disposed within the subject's ventricle.


Reference is now made to FIG. 3, which is a schematic illustration of frame 34 of elongate tube 24 and cage 44 of pump 40 of ventricular assist device 20, in accordance with some applications of the present invention. As shown, for some applications, the cage is integrally formed with the frame of the elongate tube, such that the cage is disposed within the frame of the elongate tube at the proximal end of the elongate tube. Typically, by virtue of the cage being disposed within the frame of the elongate tube at the proximal end of the elongate tube, pump 40 is disposed within a proximal portion of the elongate tube, and the longitudinal axis of the pump is aligned with the longitudinal axis of the elongate tube. For some applications, frame 34 of elongate tube 24 and cage 44 are cut from a single piece (e.g., a single tube) of a shape memory material (e.g., a shape-memory alloy, such as nitinol). Typically, by virtue of being cut from the single piece of the shape-memory the region of the tube in which the cage is disposed is able to be radially compressed to a smaller diameter than would be possible if the cage were cut from a separate piece of the shape memory material and inserted inside the elongate tube or vice versa, ceteris paribus.


Reference is now made to FIG. 4A, which is a schematic illustration of a ventricular assist device 20, in accordance with some additional applications of the present invention. For some applications, pump 40 is generally as shown in FIG. 4A. Typically, the pump includes an impeller 50, which includes an outer helical elongate element 52, which winds around a central axial spring 54, such that the helix defined by the helical elongate element is coaxial with the central axial spring. For some applications, the helical elongate element and the central axial spring are made of a shape memory material, e.g., a shape memory alloy such as nitinol. Typically, the helical elongate element and the central axial spring support a film 56 of a material (e.g., a polymer, such as polyurethane, and/or silicone) therebetween. The helical elongate element, the axial spring and the film define the impeller blade, with the helical elongate element defining the outer edge of the impeller blade (and thereby defining the outer edge of the impeller), and the axial spring defining the axis of the impeller blade. For some applications, sutures (e.g., polyester sutures, not shown) are wound around the helical elongate element, e.g., as described in WO 14/141284, which is incorporated herein by reference. Typically, the sutures are configured to facilitate bonding between the film of material (which is typically a polymer, such as polyurethane, or silicone) and the helical elongate element (which is typically a shape memory alloy, such as nitinol). For some applications, sutures (e.g., polyester sutures, not shown) are wound around spring 54. Typically, the sutures are configured to facilitate bonding between the film of material (which is typically a polymer, such as polyurethane, or silicone) and the spring (which is typically a shape memory alloy, such as nitinol).


Typically, proximal ends of both spring 54 and helical elongate element 52 are coupled to a proximal bushing (i.e., sleeve bearing) 64 of the impeller, such that the proximal ends of both spring 54 and helical elongate element 52 are disposed at a similar radial distance from the longitudinal axis of the impeller, as each other. Similarly, typically, distal ends of both spring 54 and helical elongate element 52 are coupled to a distal bushing 58 of the impeller, such that the distal ends of both spring 54 and helical elongate element 52 are disposed at a similar radial distance from the longitudinal axis of the impeller, as each other.


For some such applications, frame 34 of elongate tube 24 does not include a cage integrally formed therewith, as described hereinabove with reference to FIG. 3. Rather, for some such applications, a distal bushing 58 of the impeller is stabilized with respect to the elongate tube, by means of one or more support arms 60 that extend radially outwardly from the distal bushing of the impeller to frame 34 of elongate tube 24. As shown in FIG. 4A, for some applications, the support arms are not coupled to frame 34 of the elongate tube, but are configured to engage an inner surface of the elongate tube, to thereby stabilize the distal bushing of the impeller with respect to the elongate tube. For such applications, the support arms are typically configured to be moveable with respect to the elongate tube, by the support arms sliding along the inner surface of the elongate tube. Alternatively, even if the support arms are not integrally formed with frame 34 of the elongate tube, the support arms are coupled to frame 34 of the elongate tube (e.g., via welding, suturing, and/or an adhesive), such that, at least at the locations at which the support arms are coupled to the frame of the elongate tube, the support arms cannot undergo motion relative to the elongate tube. Further alternatively, the device includes support arms that are integrally formed with frame 34 of the elongate tube, as shown in FIG. 4B.


Reference is now made to FIG. 4B, which is a schematic illustration of device 20, the device including support arms 59, which are integrally formed with frame 34 of the elongate tube 24, the support arms being coupled to frame 34 at coupling points 61, in accordance with some applications of the present invention. Typically, the support arms are configured to extend from the distal bushing of the impeller to the coupling points, and are configured to thereby stabilize the distal bushing of the impeller with respect to the elongate tube.


With respect to device 20 as shown in FIGS. 4A-B, it is noted that for some applications, impeller 50 is disposed at a proximal end of the elongate tube, as shown, such that, during use of device 20, the impeller is disposed within the aorta, and pumps blood from the left ventricle into the aorta by rotating within the aorta. For some applications (not shown), the impeller is disposed at the distal end of the elongate tube, such that, during use of device 20, the impeller is disposed within the ventricle, and pumps blood out of the ventricle, by rotating within the ventricle. In general, in the context of the present application, the term “blood vessel” should be interpreted as including a ventricle. Similarly, an impeller that is described as being placed within a blood vessel, should be interpreted as including an impeller that is placed within a ventricle.


Reference is now made to FIGS. 5A and 5B, which are schematic illustrations of cross-sectional views of impeller 50, respectively perpendicularly to the longitudinal axis of the impeller, and along the longitudinal axis of the impeller, in accordance with some applications of the present invention. Reference is also made to FIG. 5C, which is a schematic illustration of a cross-sectional view of ventricular assist device 20 along the longitudinal axis of the device, in accordance with some applications of the present invention. As shown in FIG. 5B for example, spring 54 defines a lumen 62 therethrough. For some applications, a rigid shaft 63 is disposed along the lumen at least from proximal bushing 64 of the impeller to distal bushing 58. The rigid shaft is configured to impart rotational motion from the proximal bushing to the distal bushing, and/or to maintain the distal bushing and the proximal bushing aligned with each other and aligned with the longitudinal axis of the elongate tube. Alternatively or additionally, spring 54 itself acts as a shaft. Thus, for some applications, the spring imparts rotational motion from the proximal bushing to the distal bushing, and/or maintains the distal bushing and the proximal bushing aligned with each other and aligned with the longitudinal axis of the elongate tube. For some such applications, the spring is configured such that, when the spring is disposed in a non-radially-constrained configuration, there are substantially no gaps between windings of the spring and adjacent windings thereto.


Reference is now made to FIG. 5D, which is a schematic illustration of impeller 50 in a radially constrained (i.e., axially-elongated) configuration, in accordance with some applications of the present invention. Typically, pump 40 is inserted into the left ventricle transcatheterally, while impeller 50 is in its radially constrained configuration. As shown, in the radially constrained configuration, both helical elongate element 52 and central axial spring 54 become axially elongated, and radially constrained. Typically film 56 of the material (e.g., silicone) changes shape to conform to the shape changes of the helical elongate element and the axial support spring, both of which support the film of material. Typically, using a spring to support the inner edge of the film allows the film to change shape without the film becoming broken or collapsing inwardly onto a shaft disposed within lumen 62, due to the spring providing a large surface area to which the inner edge of the film bonds. For some applications, using a spring to support the inner edge of the film reduces a diameter to which the impeller can be radially constrained, relative to if, for example, a rigid shaft was to be used to support the inner edge of the film, since the diameter of the spring itself can be reduced by axially elongating the spring. As described hereinabove and as shown in FIG. 5C, for some applications, rigid shaft 63 is disposed along lumen 62 (defined by spring 54) at least from proximal bushing 64 of the impeller to distal bushing 58. For some applications, the rigid shaft is disposed inside the lumen even during the transcatheteral insertion of the impeller into the subject's left ventricle. Alternatively, the rigid shaft is advanced into lumen 62 once the impeller has already been released from the insertion catheter, and is disposed inside with subject's ventricle.


Referring again to FIG. 5A, typically there is a gap G, between the outer edge of the impeller and the inner surface of elongate tube 24, even at a location at which the span of the impeller is at its maximum. For some applications, it is desirable that the gap between the outer edge of the blade of the impeller and elongate tube 24 be relatively small, in order for the impeller to efficiently pump blood from the subject's left ventricle into the subject's aorta. However, it is also desirable that a gap between the outer edge of the blade of the impeller and elongate tube 24 be maintained, for example, in order to reduce a risk of hemolysis. For some applications, the gap G between the outer edge of the impeller and the inner surface of elongate tube 24, at the location at which the span of the impeller is at its maximum, is greater than 0.05 mm (e.g., greater than 0.1 mm), and/or less than 1 mm (e.g., less than 0.4 mm), e.g., 0.05 mm-1 mm, or 0.1 mm-0.4 mm). As described hereinabove, for some applications, distal bushing 58 of the impeller is stabilized with respect to the elongate tube, by means of one or more support arms 60, or support arms 59. For some applications, by stabilizing distal bushing 58 of the impeller with respect to the elongate tube, even a relatively small gap between the outer edge of the blade of the impeller and elongate tube 24 (e.g., a gap that is as described above) is maintained, during rotation of the impeller. Alternatively or additionally, a rigid shaft is inserted along the axis of the impeller via lumen 62 defined by spring 54, and the rigid shaft stabilizes distal bushing 58 of the impeller with respect to the elongate tube, such that even a relatively small gap between the outer edge of the blade of the impeller and elongate tube 24 (e.g., a gap that is as described above) is maintained, during rotation of the impeller. Further alternatively or additionally, spring 54 is sufficiently rigid as to stabilize distal bushing 58 of the impeller with respect to the elongate tube, such that even a relatively small gap between the outer edge of the blade of the impeller and elongate tube 24 (e.g., a gap that is as described above) is maintained, during rotation of the impeller.


Typically, the pitch of helical elongate element 52, when impeller 50 is in a non-radially-constrained configuration (e.g., inside the subject's ventricle), is greater than 1 mm (e.g., greater than 6 mm), and/or less than 20 mm (e.g., less than 10 mm). Typically, ceteris paribus, the greater the pitch of the helical elongate element (and therefore the impeller blade), the greater the blood flow that is generated by the impeller. Therefore, as described, the pitch of the helical elongate element 52, when impeller 50 is in the non-radially-constrained configuration, is typically greater than 1 mm (e.g., greater than 6 mm). On the other hand, it is typically desirable that the impeller occludes backflow from the subject's aorta into the subject's left ventricle during diastole. Ceteris paribus, it is typically the case that the smaller the pitch of the helical elongate element (and therefore the impeller blade), the greater the occlusion that is provided by the impeller. Therefore, as described, the pitch of the helical elongate element 52, when impeller 50 is in the non-radially-constrained configuration, is typically less than 20 mm (e.g., less than 10 mm).


For some applications, the pitch of the helical elongate element (and therefore the impeller blade) varies along the length of the helical elongate element, at least when the impeller is in a non-radially-constrained configuration. Typically, for such applications, the pitch increases from the distal end of the impeller (i.e., the end that is inserted further into the subject's body, and that is placed upstream with respect to the direction of antegrade blood flow) to the proximal end of the impeller (i.e., the end that is placed downstream with respect to the direction of antegrade blood flow), such that the pitch increases in the direction of the blood flow. Typically, the blood flow velocity increases along the impeller, along the direction of blood flow. Therefore, the pitch is increased along the direction of the blood flow, such as to further accelerate the blood.


For some applications (not shown), impeller 50 is generally as shown in FIGS. 4A-5D, but the impeller includes a plurality of helical elongate elements. For example, the impeller may include two or three helical elongate elements. Typically, the film of material is supported between the plurality of helical elongate elements and the spring, such that the impeller defines a plurality of blades. Typically, the number of impeller blades corresponds to the number of helical elongate elements that are disposed upon the impeller, e.g., as is generally described in WO 14/141284 to Schwammenthal, which is incorporated herein by reference.


Reference is now made to FIGS. 6A and 6B, which are schematic illustrations of a stator 65 of ventricular assist device 20, in accordance with some applications of the present invention. FIG. 6B shows the stator in the absence of some other elements of the ventricular assist device, for illustrative purposes. For some applications, as shown, stator 65 is disposed within a proximal portion of frame 34 of elongate tube 24. Typically, the stator includes a plurality of (e.g., more than 2, and/or less than 8) winged projections 66 that, when device 20 is in a non-radially constrained configuration, extend from frame 34, and that are made of a flexible material, e.g., a polymer, such as polyurethane, and/or silicone. The winged projections are typically configured to define planes that are parallel to the longitudinal axis of the elongate tube, and are thereby configured to stabilize turbulent blood flow that is generated by the impeller, by directing blood flow along the direction of the longitudinal axis of the elongate tube.


It is noted that, as shown in FIG. 6A, typically elongate tube 24 includes blood impermeable material 36 that is disposed upon frame 34 of the tube. For example, the blood impermeable material may include polyurethane, polyester, or silicone, as described hereinabove. It is noted that, typically, the elongate tube includes the blood impermeable material, even though, for illustrative purposes, the blood impermeable material of the tube is not shown in all of the figures of the present application.


As shown in FIG. 6B, for some applications, sutures 68 are wound around portions of frame 34, in order to facilitate coupling between the winged projections and frame 34, in accordance with the techniques described hereinabove. For some applications, the winged projections extend from frame 34 to an axial support element 69. Typically, the axial support element is a tubular element formed of metal, plastic, and/or a polymer (such as polyurethane and/or silicone). For some applications, stator 65 is integrally formed with frame 34 of elongate tube 24. Alternatively or additionally, the stator is formed separately from the elongate tube.


As described hereinabove, typically, device 20 is inserted into the subject's ventricle transcatheterally, while elongate tube 24 is in a radially constrained state. Upon being released from the catheter, the tube automatically assumes it tubular shape, due to frame 34 of elongate tube 24 self-expanding. Typically, the stator is inserted into subject's left ventricle inside the elongate tube. During the insertion, the winged projections of the stator are in folded states, and do not substantially increase the minimal diameter to which the elongate tube can be radially-constrained, relative to if the tube did not contain the winged projections. Upon frame 34 of the elongate tube expanding, the winged projections are configured to automatically assume their winged configurations, due to the winged projections being coupled to frame 34.


It is noted that, although FIGS. 1A and 1B show ventricular assist device 20 in the subject's left ventricle, for some applications, device 20 is placed inside the subject's right ventricle, such that the device traverses the subject's pulmonary valve, and techniques described herein are applied, mutatis mutandis. Alternatively or additionally, device 20 and/or a portion thereof (e.g., impeller 50, even in the absence of elongate tube 24) is placed inside a different portion of the subject's body, in order to assist with the pumping of blood from that portion. For example, device 20 and/or a portion thereof (e.g., impeller 50, even in the absence of elongate tube 24) may be placed in a blood vessel and may be used to pump blood through the blood vessel. For some applications, device 20 and/or a portion thereof (e.g., impeller 50, even in the absence of elongate tube 24) is configured to be placed within the subclavian vein or jugular vein, at junctions of the vein with a lymph duct, and is used to increase flow of lymphatic fluid from the lymph duct into the vein, mutatis mutandis.


Reference is now made to FIG. 7A, which is a schematic illustration of a ventricular assist device 70 that includes a centrifugal pump 72, in accordance with some applications of the present invention. Reference is also made to FIGS. 7B and 7C, which show, respectively, three-dimensional and two-dimensional cross-sectional views of the centrifugal pump, in accordance with some applications of the present invention.


For some applications, ventricular assist device assists pumping of a ventricle (e.g., left ventricle 22) by using centrifugal pump to pump blood from the subject's left ventricle, out of the subject body, and into the subject's aorta 30. For some applications, a catheter 74 is inserted into the subject's vasculature that extends from centrifugal pump 72 to the subject's ventricle. As shown in FIGS. 7B and 7C, typically, catheter 74 defines concentric tubes 76 and 78. Blood is pumped out of the subject's left ventricle via a first one of concentric tubes (e.g., inner tube 76, as indicated by the dashed arrows indicating the direction of blood flow in FIG. 7C), and blood is pumped into the subject's aorta via a second one of the concentric tubes (e.g., outer tube 78, as shown in FIG. 7C). Typically, the first and second tubes are inserted into the subject's body via a single insertion point, e.g., femoral artery 80, as shown in FIG. 7A, or via a different insertion point, such as the subclavian artery. For some applications, centrifugal pump 72 defines an additional tube 82, via which blood pressure is measured.


The scope of the present invention includes combining any of the apparatus and methods described herein with any of the apparatus and methods described in one or more of the following applications, all of which are incorporated herein by reference:

    • International Patent Application PCT/IL2017/051092 to Tuval (published as WO 18/061002), filed Sep. 28, 2017, entitled “Blood vessel tube,” which US Provisional Patent Application 62/401,403 to Tuval, filed Sep. 29, 2016;
    • International Patent Application PCT/IL2016/050525 to Schwammenthal (published as WO 16/185473), filed May 18, 2016, entitled “Blood pump,” which claims priority from U.S. Provisional Patent Application 62/162,881 to Schwammenthal, filed May 18, 2015, entitled “Blood pump;”
    • International Patent Application PCT/IL2015/050532 to Schwammenthal (published as WO 15/177793), filed May 19, 2015, entitled “Blood pump,” which claims priority from U.S. Provisional Patent Application 62/000,192 to Schwammenthal, filed May 19, 2014, entitled “Blood pump;”
    • International Patent Application PCT/IL2014/050289 to Schwammenthal (published as WO 14/141284), filed Mar. 13, 2014, entitled “Renal pump,” which claims priority from (a) U.S. Provisional Patent Application 61/779,803 to Schwammenthal, filed Mar. 13, 2013, entitled “Renal pump,” and (b) U.S. Provisional Patent Application 61/914,475 to Schwammenthal, filed Dec. 11, 2013, entitled “Renal pump;”
    • U.S. patent application Ser. No. 14/567,439 to Tuval (published as US 2015/0157777), filed Dec. 11, 2014, entitled “Curved catheter,” which claims priority from U.S. Provisional Patent Application 61/914,470 to Tuval, filed Dec. 11, 2013, entitled “Curved catheter;” and
    • International Patent Application PCT/IL2013/050495 to Tuval (published as WO 13/183060), filed Jun. 6, 2013, entitled “Prosthetic renal valve,” which claims priority from U.S. Provisional Patent Application 61/656,244 to Tuval, filed Jun. 6, 2012, entitled “Prosthetic renal valve.”


There is therefore provided, in accordance with some applications of the present invention, the following inventive concepts:


Inventive concept 1. Apparatus comprising:






    • a left ventricular assist device configured to assist left ventricular functioning of a subject, the left ventricular assist device comprising:
      • an elongate tube configured to traverse an aortic valve of the subject, such that a proximal end of the tube is disposed within an aorta of the subject and a distal end of the tube is disposed within a left ventricle of the subject, the elongate tube comprising:
        • a frame formed from a shape-memory alloy; and
        • a blood impermeable material that is disposed upon the frame;
      • a rotatable impeller configured to pump blood from the subject's left ventricle to the subject's aorta by rotating; and
      • a plurality of winged projections that are coupled to the elongate tube such that planes defined by the winged projections are parallel with a longitudinal axis of the elongate tube, the winged projections being configured to stabilize turbulent blood flow that is generated by rotation of the impeller, by directing blood flow along a direction of the longitudinal axis of the elongate tube.


        Inventive concept 2. The apparatus according to inventive concept 1, wherein the elongate tube is configured to be inserted into a body of the subject transcatheterally, while in a radially-constrained configuration, and wherein the winged projections are configured to become folded, when the elongate tube is in its radially-constrained configuration.


        Inventive concept 3. A method comprising:

    • placing an elongate tube into a body of a subject, such that the elongate tube traverses an aortic valve of the subject, such that a proximal end of the tube is disposed within an aorta of the subject and a distal end of the tube is disposed within a left ventricle of the subject, the elongate tube including:
      • a frame formed from a shape-memory alloy, and
      • a blood impermeable material that is disposed upon the frame; and

    • pumping blood from the subject's left ventricle to the subject's aorta by rotating an impeller that is disposed within the elongate tube,

    • a plurality of winged projections being coupled to the elongate tube such that planes defined by the winged projections are parallel with a longitudinal axis of the elongate tube, the winged projections being configured to stabilize turbulent blood flow that is generated by rotation of the impeller, by directing blood flow along a direction of the longitudinal axis of the elongate tube.


      Inventive concept 4. The method according to claim inventive concept 3, wherein placing the elongate tube into the subject's body comprises placing the elongate tube into the subject's body transcatheterally while the elongate tube is in a radially-constrained configuration, the winged projections being configured to become folded, when the elongate tube is in its radially-constrained configuration.


      Inventive concept 5. Apparatus comprising:

    • a left ventricular assist device configured to assist left ventricular functioning of a subject, the left ventricular assist device comprising:
      • an elongate tube configured to traverse an aortic valve of the subject, such that a proximal end of the tube is disposed within an aorta of the subject and a distal end of the tube is disposed within a left ventricle of the subject, the elongate tube comprising:
        • a frame formed from a shape-memory alloy; and
        • a blood impermeable material that is disposed upon the frame; and
      • a pump comprising a rotatable impeller and a cage disposed around the rotatable impeller,
        • the cage being integrally formed with the elongate tube such that the cage is disposed within the frame of the elongate tube at the proximal end of the elongate tube, the pump thereby being disposed within a proximal portion of the elongate tube, and a longitudinal axis of the pump thereby being aligned with a longitudinal axis of the elongate tube.


          Inventive concept 6. A method comprising:

    • placing, into a subject's body, a left ventricular assist device configured to assist left ventricular functioning of a subject, the left ventricular assist device including:
      • an elongate tube configured to traverse an aortic valve of the subject, such that a proximal end of the tube is disposed within an aorta of the subject and a distal end of the tube is disposed within a left ventricle of the subject, the elongate tube including:
        • a frame formed from a shape-memory alloy, and
        • a blood impermeable material that is disposed upon the frame, and
      • a pump comprising a rotatable impeller and a cage disposed around the rotatable impeller,
        • the cage being integrally formed with the elongate tube such that the cage is disposed within the frame of the elongate tube at the proximal end of the elongate tube, the pump thereby being disposed within a proximal portion of the elongate tube, and a longitudinal axis of the pump thereby being aligned with a longitudinal axis of the elongate tube; and

    • pumping blood from the subject's left ventricle to the subject's aorta by rotating the impeller,


      Inventive concept 7. A blood pump for pumping blood from a first location in a body of a subject to a second location in the subject's body, the blood pump comprising:

    • a first tube for pumping the blood away from the first location;

    • a second tube for pumping the blood toward to second location, the first and second tubes being coaxial with respect to each other; and

    • a centrifugal pump configured to pump the blood through the first and second tubes.


      Inventive concept 8. A method comprising:

    • pumping blood from a first location in a body of a subject to a second location in the subject's body, by:
      • pumping the blood away from the first location via a first tube;
      • pumping the blood toward to second location via a second tube, the first and second tubes being coaxial with respect to each other; and
      • using a centrifugal pump to pump the blood through the first and second tubes.





It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims
  • 1. Apparatus comprising: a rotating impeller comprising: proximal and distal bushings;at least one impeller blade comprising: at least one helical elongate element;a coil spring, the coil spring being disposed inside of the helical elongate element between the proximal and distal bushings, and the coil spring defining a lumen therethrough; anda film of material supported between the helical elongate element and the coil spring, wherein the impeller is structured such that the film of material extends from the helical elongate element to the coil spring to thereby define the impeller blade; anda rigid shaft configured to extend from the proximal bushing to the distal bushing via the lumen defined by the coil spring, such that the coil spring extends around the rigid shaft.
  • 2. The apparatus according to claim 1, wherein the impeller is configured to be placed within the subject's left ventricle.
  • 3. The apparatus according to claim 1, wherein the impeller comprises a plurality of helical elongate elements, and the film of material is supported between the plurality of helical elongate elements and the coil spring, such that the impeller defines a plurality of blades.
  • 4. The apparatus according to claim 1, wherein, when the impeller is disposed in a non-radially-constrained configuration, a pitch of the helical elongate element varies along a length of the helical elongate element.
  • 5. The apparatus according to claim 1, wherein the impeller is configured to be radially constrained by the helical elongate element and the coil spring being axially elongated, and wherein in response to the axial elongation of the helical elongate element and the coil spring, the film is configured to change shape without the film of material breaking.
  • 6. The apparatus according to claim 1, wherein the coil spring, when disposed in a non-radially-constrained configuration thereof, is configured such that there are substantially no gaps between windings of the coil spring and adjacent windings thereto.
  • 7. The apparatus according to claim 1, further comprising: a tube configured to traverse an aortic valve of a subject, such that a proximal end of the tube is disposed within an aorta of the subject and a distal end of the tube is disposed within a left ventricle of the subject, the tube comprising a blood-impermeable material; anda frame disposed within at least a portion of the tube,wherein the impeller is configured to be disposed within the tube, and to rotate such as to pump blood from the left ventricle to the aorta.
  • 8. The apparatus according to claim 7, wherein the rigid shaft is configured to stabilize the impeller with respect to the tube, during rotation of the impeller, such that a gap between the outer edge of the impeller and the inner surface of the tube is maintained.
  • 9. The apparatus according to claim 7, wherein the impeller and the tube are configured such that, when the impeller and the tube are deployed within the subject, a gap between an outer edge of the impeller and an inner surface of the tube is less than 1 mm.
  • 10. The apparatus according to claim 9, wherein the impeller and the tube are configured such that, when the impeller and the tube are deployed within the subject, the gap between the outer edge of the impeller and the inner surface of the tube is less than 0.4 mm.
  • 11. The apparatus according to claim 9, wherein the impeller is configured to be stabilized with respect to the tube, such that, during rotation of the impeller, the gap between the outer edge of the impeller and the inner surface of the tube is maintained.
CROSS-REFERENCES TO RELATED APPLICATIONS

The present application is a continuation of International Application No. PCT/IL2017/051158 to Tuval (published as WO 18/078615), entitled “Ventricular assist device,” filed Oct. 23, 2017, which claims priority from: U.S. Provisional Patent Application 62/412,631 to Tuval, entitled “Ventricular assist device,” filed Oct. 25, 2016; andU.S. Provisional Patent Application 62/543,540 to Tuval, entitled “Ventricular assist device,” filed Aug. 10, 2017.U.S. Provisional Patent Application 62/412,631 and U.S. Provisional Patent Application 62/543,540 are incorporated herein by reference.

US Referenced Citations (531)
Number Name Date Kind
3592183 Watkins et al. Jul 1971 A
4625712 Wampler Dec 1986 A
4753221 Kensey et al. Jun 1988 A
4919647 Nash Apr 1990 A
4944722 Carriker et al. Jul 1990 A
4954055 Raible et al. Sep 1990 A
4957504 Chardack Sep 1990 A
4964864 Summers et al. Oct 1990 A
4969865 Hwang et al. Nov 1990 A
4985014 Orejola Jan 1991 A
5011469 Buckberg et al. Apr 1991 A
5061256 Wampler Oct 1991 A
5169378 Figuera Dec 1992 A
5275580 Yamazaki Jan 1994 A
5531789 Yamazaki et al. Jul 1996 A
5569275 Kotula et al. Oct 1996 A
5613935 Jarvik Mar 1997 A
5692882 Bozeman, Jr. et al. Dec 1997 A
5713730 Nose et al. Feb 1998 A
5749855 Reitan May 1998 A
5772693 Brownlee Jun 1998 A
5843158 Lenker et al. Dec 1998 A
5863179 Westphal et al. Jan 1999 A
5876385 Ikari et al. Mar 1999 A
5879499 Corvi Mar 1999 A
5911685 Siess et al. Jun 1999 A
5928132 Leschinsky Jul 1999 A
5947892 Benkowski et al. Sep 1999 A
5964694 Siess et al. Oct 1999 A
6007478 Siess et al. Dec 1999 A
6086527 Talpade Jul 2000 A
6116862 Rau et al. Sep 2000 A
6135729 Aber Oct 2000 A
6136025 Barbut et al. Oct 2000 A
6162017 Raible Dec 2000 A
6176848 Rau et al. Jan 2001 B1
6183220 Ohara et al. Feb 2001 B1
6217541 Yu Apr 2001 B1
6247892 Kazatchkov et al. Jun 2001 B1
6355001 Quinn et al. Mar 2002 B1
6413222 Pantages et al. Jul 2002 B1
6482228 Norred Nov 2002 B1
6506146 Mohl Jan 2003 B1
6533716 Schmutz-Rode et al. Mar 2003 B1
6537315 Yamazaki et al. Mar 2003 B2
6544216 Sammler et al. Apr 2003 B1
6592567 Levin et al. Jul 2003 B1
6616624 Kieval Sep 2003 B1
6884210 Nose et al. Apr 2005 B2
6949066 Bearnson et al. Sep 2005 B2
7004925 Navia et al. Feb 2006 B2
7010954 Siess et al. Mar 2006 B2
7011620 Siess Mar 2006 B1
7022100 Aboul-hosn et al. Apr 2006 B1
7027875 Siess et al. Apr 2006 B2
7070555 Siess Jul 2006 B2
7144364 Barbut et al. Dec 2006 B2
7159593 Mccarthy et al. Jan 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7258679 Moore et al. Aug 2007 B2
7335192 Keren et al. Feb 2008 B2
7338521 Antaki et al. Mar 2008 B2
7341570 Keren et al. Mar 2008 B2
7393181 Mcbride et al. Jul 2008 B2
7485104 Kieval Feb 2009 B2
7717952 Case et al. May 2010 B2
7744642 Rittgers et al. Jun 2010 B2
7762941 Jarvik Jul 2010 B2
7766853 Lane Aug 2010 B2
7766892 Keren et al. Aug 2010 B2
7766961 Patel et al. Aug 2010 B2
7780628 Keren et al. Aug 2010 B1
7811221 Gross Oct 2010 B2
7841976 McBride et al. Nov 2010 B2
7914436 Kung Mar 2011 B1
7914503 Goodson et al. Mar 2011 B2
7927068 Mcbride et al. Apr 2011 B2
8012121 Goodson et al. Sep 2011 B2
8079948 Shifflette Dec 2011 B2
8118723 Richardson et al. Feb 2012 B2
8123669 Siess et al. Feb 2012 B2
8157758 Pecor et al. Apr 2012 B2
8192451 Cambronne et al. Jun 2012 B2
8216122 Kung Jul 2012 B2
8221492 Case et al. Jul 2012 B2
8235933 Keren et al. Aug 2012 B2
8277470 Demarais et al. Oct 2012 B2
8376707 Mcbride et al. Feb 2013 B2
8439859 Pfeffer et al. May 2013 B2
8449443 Rodefeld et al. May 2013 B2
8485961 Campbell et al. Jul 2013 B2
8489190 Pfeffer et al. Jul 2013 B2
8512262 Gertner Aug 2013 B2
8535211 Walters et al. Sep 2013 B2
8538535 Ariav et al. Sep 2013 B2
8579858 Reitan et al. Nov 2013 B2
8591393 Walters et al. Nov 2013 B2
8591539 Gellman Nov 2013 B2
8597170 Walters et al. Dec 2013 B2
8617239 Reitan Dec 2013 B2
8672868 Simons Mar 2014 B2
8684904 Campbell et al. Apr 2014 B2
8690749 Nunez Apr 2014 B1
8721516 Scheckel May 2014 B2
8721517 Zeng et al. May 2014 B2
8727959 Reitan et al. May 2014 B2
8734331 Evans et al. May 2014 B2
8734508 Hastings et al. May 2014 B2
8777832 Wang et al. Jul 2014 B1
8814543 Liebing Aug 2014 B2
8814776 Hastie et al. Aug 2014 B2
8814933 Siess Aug 2014 B2
8827887 Curtis et al. Sep 2014 B2
8849398 Evans Sep 2014 B2
8864642 Scheckel Oct 2014 B2
8888728 Aboul-hosn et al. Nov 2014 B2
8900060 Liebing Dec 2014 B2
8926492 Scheckel Jan 2015 B2
8932141 Liebing Jan 2015 B2
8944748 Liebing Feb 2015 B2
8979493 Roehn Mar 2015 B2
8992163 Mcbride et al. Mar 2015 B2
8998792 Scheckel Apr 2015 B2
9028216 Schumacher et al. May 2015 B2
9067006 Toellner Jun 2015 B2
9072825 Pfeffer et al. Jul 2015 B2
9089634 Schumacher et al. Jul 2015 B2
9138518 Campbell Sep 2015 B2
9162017 Evans et al. Oct 2015 B2
9162019 Horvath et al. Oct 2015 B2
9217442 Wiessler et al. Dec 2015 B2
9259521 Simons Feb 2016 B2
9278189 Corbett Mar 2016 B2
9314558 Er Apr 2016 B2
9327067 Zeng et al. May 2016 B2
9328741 Liebing May 2016 B2
9339596 Roehn May 2016 B2
9358329 Fitzgerald et al. Jun 2016 B2
9358330 Schumacher Jun 2016 B2
9364592 Mcbride et al. Jun 2016 B2
9364593 Mcbride et al. Jun 2016 B2
9370613 Hsu et al. Jun 2016 B2
9381288 Schenck et al. Jul 2016 B2
9393384 Kapur et al. Jul 2016 B1
9402942 Hastie et al. Aug 2016 B2
9404505 Scheckel Aug 2016 B2
9416783 Schumacher et al. Aug 2016 B2
9416791 Toellner Aug 2016 B2
9421311 Tanner et al. Aug 2016 B2
9446179 Keenan et al. Sep 2016 B2
9474840 Siess Oct 2016 B2
9512839 Liebing Dec 2016 B2
9533082 Reichenbach et al. Jan 2017 B2
9533084 Siess et al. Jan 2017 B2
9545468 Aboul-hosn et al. Jan 2017 B2
9550017 Spanier et al. Jan 2017 B2
9561314 Aboul-hosn et al. Feb 2017 B2
9572915 Heuring et al. Feb 2017 B2
9597205 Tuval Mar 2017 B2
9597437 Aboul-hosn et al. Mar 2017 B2
9603983 Roehn et al. Mar 2017 B2
9611743 Toellner et al. Apr 2017 B2
9616159 Anderson et al. Apr 2017 B2
9623161 Medvedev et al. Apr 2017 B2
9669142 Spanier et al. Jun 2017 B2
9669144 Spanier et al. Jun 2017 B2
9675738 Tanner et al. Jun 2017 B2
9675740 Zeng et al. Jun 2017 B2
9713663 Medvedev et al. Jul 2017 B2
9717833 Mcbride et al. Aug 2017 B2
9750860 Schumacher Sep 2017 B2
9750861 Hastie et al. Sep 2017 B2
9759237 Liebing Sep 2017 B2
9764113 Tuval et al. Sep 2017 B2
9771801 Schumacher et al. Sep 2017 B2
9789238 Aboul-hosn et al. Oct 2017 B2
9795727 Schumacher Oct 2017 B2
9814814 Corbett et al. Nov 2017 B2
9821146 Tao et al. Nov 2017 B2
9827356 Muller et al. Nov 2017 B2
9833550 Siess Dec 2017 B2
9835550 Kakuno et al. Dec 2017 B2
9850906 Ozaki et al. Dec 2017 B2
9872947 Keenan et al. Jan 2018 B2
9872948 Siess Jan 2018 B2
9878079 Pfeffer et al. Jan 2018 B2
9889242 Pfeffer et al. Feb 2018 B2
9895475 Toellner et al. Feb 2018 B2
9903384 Roehn Feb 2018 B2
9907890 Muller Mar 2018 B2
9907891 Wiessler et al. Mar 2018 B2
9919087 Pfeffer et al. Mar 2018 B2
9962475 Campbell et al. May 2018 B2
9964115 Scheckel May 2018 B2
9974893 Toellner May 2018 B2
9999714 Spanier et al. Jun 2018 B2
10029037 Muller et al. Jul 2018 B2
10029040 Taskin Jul 2018 B2
10039872 Zeng et al. Aug 2018 B2
10039874 Schwammenthal et al. Aug 2018 B2
10052419 Er Aug 2018 B2
10052420 Medvedev et al. Aug 2018 B2
10071192 Zeng Sep 2018 B2
10086121 Fitzgerald et al. Oct 2018 B2
10105475 Muller Oct 2018 B2
10107299 Scheckel Oct 2018 B2
10117980 Keenan et al. Nov 2018 B2
10119550 Bredenbreuker et al. Nov 2018 B2
10149932 Mcbride et al. Dec 2018 B2
10172985 Simon et al. Jan 2019 B2
10179197 Kaiser et al. Jan 2019 B2
10183104 Anderson et al. Jan 2019 B2
10196899 Toellner et al. Feb 2019 B2
10207037 Corbett et al. Feb 2019 B2
10208763 Schumacher et al. Feb 2019 B2
10215187 Mcbride et al. Feb 2019 B2
10221866 Liebing Mar 2019 B2
10231838 Chin et al. Mar 2019 B2
10238783 Aboul-hosn et al. Mar 2019 B2
10245363 Rowe Apr 2019 B1
10265447 Campbell et al. Apr 2019 B2
10265448 Liebing Apr 2019 B2
10279095 Aboul-hosn et al. May 2019 B2
10300185 Aboul-hosn et al. May 2019 B2
10300186 Aboul-hosn et al. May 2019 B2
10316853 Toellner Jun 2019 B2
10330101 Toellner Jun 2019 B2
10342904 Schumacher Jul 2019 B2
10342906 D'Ambrosio et al. Jul 2019 B2
10363349 Muller et al. Jul 2019 B2
10369260 Smith et al. Aug 2019 B2
10376162 Edelman et al. Aug 2019 B2
10413646 Wiessler et al. Sep 2019 B2
10449276 Pfeffer et al. Oct 2019 B2
10449279 Muller Oct 2019 B2
10478538 Scheckel et al. Nov 2019 B2
10478539 Pfeffer et al. Nov 2019 B2
10478540 Scheckel et al. Nov 2019 B2
10495101 Scheckel Dec 2019 B2
10557475 Roehn Feb 2020 B2
10583231 Schwammenthal et al. Mar 2020 B2
10584589 Schumacher et al. Mar 2020 B2
10589012 Toellner et al. Mar 2020 B2
10617808 Hastie et al. Apr 2020 B2
10662967 Scheckel May 2020 B2
10669855 Toellner et al. Jun 2020 B2
10765789 Zeng et al. Sep 2020 B2
10792406 Roehn et al. Oct 2020 B2
10799624 Pfeffer et al. Oct 2020 B2
10799626 Siess et al. Oct 2020 B2
10801511 Siess et al. Oct 2020 B2
10806838 Er Oct 2020 B2
10835653 Liebing Nov 2020 B2
10857272 Liebing Dec 2020 B2
10864309 Mcbride et al. Dec 2020 B2
10865801 Mcbride et al. Dec 2020 B2
10874783 Pfeffer et al. Dec 2020 B2
10881770 Tuval et al. Jan 2021 B2
10881845 Siess et al. Jan 2021 B2
10894115 Pfeffer et al. Jan 2021 B2
10898629 Siess et al. Jan 2021 B2
10907646 Bredenbreuker et al. Feb 2021 B2
10920596 Toellner et al. Feb 2021 B2
10926013 Schumacher et al. Feb 2021 B2
10935038 Siess Mar 2021 B2
10980927 Pfeffer et al. Apr 2021 B2
10994120 Tuval et al. May 2021 B2
11007350 Tao et al. May 2021 B2
11020584 Siess et al. Jun 2021 B2
11027114 D'Ambrosio et al. Jun 2021 B2
11033729 Scheckel et al. Jun 2021 B2
11040187 Wiessler et al. Jun 2021 B2
RE48649 Siess Jul 2021 E
11116960 Simon et al. Sep 2021 B2
11123539 Pfeffer et al. Sep 2021 B2
11129978 Pfeffer et al. Sep 2021 B2
11167124 Pfeffer et al. Nov 2021 B2
11168705 Liebing Nov 2021 B2
11185680 Tuval et al. Nov 2021 B2
11191944 Tuval et al. Dec 2021 B2
11197690 Fantuzzi et al. Dec 2021 B2
11219755 Siess et al. Jan 2022 B2
11229786 Zeng et al. Jan 2022 B2
11253692 Schumacher Feb 2022 B2
11253693 Pfeffer et al. Feb 2022 B2
11260212 Tuval et al. Mar 2022 B2
11260215 Scheckel et al. Mar 2022 B2
11266824 Er Mar 2022 B2
11268521 Toellner Mar 2022 B2
11273301 Pfeffer et al. Mar 2022 B2
11278711 Liebing Mar 2022 B2
11280345 Bredenbreuker et al. Mar 2022 B2
11291825 Tuval et al. Apr 2022 B2
11298525 Jahangir Apr 2022 B2
11305105 Corbett et al. Apr 2022 B2
11313228 Schumacher et al. Apr 2022 B2
11338124 Pfeffer et al. May 2022 B2
11351358 Nix et al. Jun 2022 B2
11364373 Corbett et al. Jun 2022 B2
11421701 Schumacher et al. Aug 2022 B2
11434922 Roehn Sep 2022 B2
20010041934 Yamazaki et al. Nov 2001 A1
20020107536 Hussein Aug 2002 A1
20020151799 Pantages et al. Oct 2002 A1
20030055486 Adams et al. Mar 2003 A1
20030088310 Hansen et al. May 2003 A1
20030100816 Siess May 2003 A1
20030149473 Chouinard et al. Aug 2003 A1
20030208097 Aboul-Hosn et al. Nov 2003 A1
20040064090 Keren et al. Apr 2004 A1
20040064091 Keren et al. Apr 2004 A1
20040111006 Alferness et al. Jun 2004 A1
20040116769 Jassawalla et al. Jun 2004 A1
20040167415 Gelfand et al. Aug 2004 A1
20040210236 Allers et al. Oct 2004 A1
20040260389 Case et al. Dec 2004 A1
20050033406 Barnhart et al. Feb 2005 A1
20050049692 Numamoto et al. Mar 2005 A1
20050079274 Palasis et al. Apr 2005 A1
20050085848 Johnson et al. Apr 2005 A1
20050119682 Nguyen et al. Jun 2005 A1
20050137680 Ortiz et al. Jun 2005 A1
20050180854 Grabau et al. Aug 2005 A1
20060062672 Mcbride et al. Mar 2006 A1
20060064059 Gelfand et al. Mar 2006 A1
20060106449 Ben May 2006 A1
20060135961 Rosenman et al. Jun 2006 A1
20060155322 Sater et al. Jul 2006 A1
20060265051 Caro et al. Nov 2006 A1
20070100415 Licata et al. May 2007 A1
20070100435 Case et al. May 2007 A1
20070142729 Pfeiffer et al. Jun 2007 A1
20070162103 Case et al. Jul 2007 A1
20070208291 Patel Sep 2007 A1
20070260327 Case et al. Nov 2007 A1
20070282243 Pini et al. Dec 2007 A1
20070293808 Williams et al. Dec 2007 A1
20080009668 Cohn Jan 2008 A1
20080103591 Siess May 2008 A1
20080114339 McBride et al. May 2008 A1
20080132747 Shifflette Jun 2008 A1
20080132748 Shifflette Jun 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080154236 Elkins et al. Jun 2008 A1
20080183280 Agnew et al. Jul 2008 A1
20080306327 Shifflette Dec 2008 A1
20090024195 Rezai et al. Jan 2009 A1
20090062597 Shifflette Mar 2009 A1
20090093764 Pfeffer et al. Apr 2009 A1
20090093796 Pfeffer et al. Apr 2009 A1
20090264991 Paul et al. Oct 2009 A1
20090287299 Tabor et al. Nov 2009 A1
20090318857 Goodson et al. Dec 2009 A1
20100049313 Alon et al. Feb 2010 A1
20100130810 Mohl May 2010 A1
20100152523 MacDonald et al. Jun 2010 A1
20100268017 Siess Oct 2010 A1
20110004046 Campbell et al. Jan 2011 A1
20110034874 Reitan et al. Feb 2011 A1
20110106244 Ferrari et al. May 2011 A1
20110112567 Lenker et al. May 2011 A1
20110152999 Hastings et al. Jun 2011 A1
20110190874 Celermajer et al. Aug 2011 A1
20110213408 Gross et al. Sep 2011 A1
20110230949 Haverkost et al. Sep 2011 A1
20110257462 Rodefeld et al. Oct 2011 A1
20110264075 Leung et al. Oct 2011 A1
20110282128 Reitan et al. Nov 2011 A1
20110282274 Fulton Nov 2011 A1
20110301662 Bar-yoseph et al. Dec 2011 A1
20120022579 Fulton Jan 2012 A1
20120059460 Reitan Mar 2012 A1
20120089047 Ryba et al. Apr 2012 A1
20120089225 Akkerman et al. Apr 2012 A1
20120116382 Ku et al. May 2012 A1
20120130469 Cragg et al. May 2012 A1
20120143141 Verkaik et al. Jun 2012 A1
20120172654 Bates Jul 2012 A1
20120172655 Campbell et al. Jul 2012 A1
20120172656 Walters et al. Jul 2012 A1
20120178985 Walters et al. Jul 2012 A1
20120178986 Campbell et al. Jul 2012 A1
20120224970 Schumacher et al. Sep 2012 A1
20120234411 Scheckel Sep 2012 A1
20120237353 Schumacher et al. Sep 2012 A1
20120237357 Schumacher et al. Sep 2012 A1
20120245680 Masuzawa et al. Sep 2012 A1
20120303112 Armstrong et al. Nov 2012 A1
20120316586 Demarais et al. Dec 2012 A1
20120328460 Horvath et al. Dec 2012 A1
20130053623 Evans et al. Feb 2013 A1
20130053732 Heuser Feb 2013 A1
20130060077 Liebing Mar 2013 A1
20130079874 Doss et al. Mar 2013 A1
20130085318 Toellner Apr 2013 A1
20130085319 Evans et al. Apr 2013 A1
20130177407 Farineau et al. Jul 2013 A1
20130177409 Schumacher et al. Jul 2013 A1
20130177432 Toellner et al. Jul 2013 A1
20130237744 Pfeffer et al. Sep 2013 A1
20130303831 Evans Nov 2013 A1
20130303969 Keenan et al. Nov 2013 A1
20140018840 Morgan et al. Jan 2014 A1
20140025041 Fukuoka et al. Jan 2014 A1
20140128659 Heuring et al. May 2014 A1
20140255176 Bredenbreuker et al. Sep 2014 A1
20140275720 Ferrari Sep 2014 A1
20140275722 Zimmermann et al. Sep 2014 A1
20140350523 Dehdashtian et al. Nov 2014 A1
20150005570 Fritz et al. Jan 2015 A1
20150018597 Fierens et al. Jan 2015 A1
20150119633 Haselby et al. Apr 2015 A1
20150157777 Tuval et al. Jun 2015 A1
20150164662 Tuval Jun 2015 A1
20150176582 Liebing Jun 2015 A1
20150258262 Pfeffer et al. Sep 2015 A1
20150290372 Muller et al. Oct 2015 A1
20150328382 Corbett et al. Nov 2015 A1
20150343136 Nitzan et al. Dec 2015 A1
20150343179 Schumacher et al. Dec 2015 A1
20150343186 Nitzan et al. Dec 2015 A1
20160022890 Schwammenthal et al. Jan 2016 A1
20160051741 Schwammenthal et al. Feb 2016 A1
20160053768 Schumacher et al. Feb 2016 A1
20160106896 Pfeffer et al. Apr 2016 A1
20160129170 Siess May 2016 A1
20160136341 Pfeffer et al. May 2016 A1
20160136342 Pfeffer et al. May 2016 A1
20160136343 Anagnostopoulos May 2016 A1
20160144089 Woo et al. May 2016 A1
20160184500 Zeng Jun 2016 A1
20160256620 Scheckel et al. Sep 2016 A1
20160279310 Scheckel et al. Sep 2016 A1
20160331378 Nitzan et al. Nov 2016 A1
20160354525 Mcbride et al. Dec 2016 A1
20170007403 Wildhirt et al. Jan 2017 A1
20170014562 Liebing Jan 2017 A1
20170028115 Muller Feb 2017 A1
20170035954 Muller et al. Feb 2017 A1
20170049946 Kapur et al. Feb 2017 A1
20170071769 Mangiardi Mar 2017 A1
20170087286 Spanier et al. Mar 2017 A1
20170087288 Groß-hardt et al. Mar 2017 A1
20170100527 Schwammenthal et al. Apr 2017 A1
20170173237 Pfeifer et al. Jun 2017 A1
20170197021 Nitzan et al. Jul 2017 A1
20170215918 Tao et al. Aug 2017 A1
20170232168 Reichenbach et al. Aug 2017 A1
20170232171 Roehn et al. Aug 2017 A1
20170290964 Barry Oct 2017 A1
20170333067 Wilson Nov 2017 A1
20170333607 Zarins Nov 2017 A1
20170340791 Aboul-hosn et al. Nov 2017 A1
20170348470 D'ambrosio et al. Dec 2017 A1
20180050142 Siess et al. Feb 2018 A1
20180055979 Corbett et al. Mar 2018 A1
20180064861 Dur et al. Mar 2018 A1
20180080326 Schumacher et al. Mar 2018 A1
20180100507 Wu et al. Apr 2018 A1
20180104453 Tao et al. Apr 2018 A1
20180149164 Siess May 2018 A1
20180149165 Siess et al. May 2018 A1
20180169312 Barry Jun 2018 A1
20180169313 Schwammenthal et al. Jun 2018 A1
20180207334 Siess Jul 2018 A1
20180228952 Pfeffer et al. Aug 2018 A1
20180228953 Siess et al. Aug 2018 A1
20180264182 Spanier et al. Sep 2018 A1
20180264183 Jahangir Sep 2018 A1
20180280598 Curran et al. Oct 2018 A1
20180289877 Schumacher et al. Oct 2018 A1
20180303990 Siess et al. Oct 2018 A1
20180303992 Taskin Oct 2018 A1
20180303993 Schwammenthal et al. Oct 2018 A1
20180353667 Moyer et al. Dec 2018 A1
20190015570 Muller Jan 2019 A1
20190030228 Keenan et al. Jan 2019 A1
20190046702 Siess et al. Feb 2019 A1
20190060539 Siess et al. Feb 2019 A1
20190070345 Mcbride et al. Mar 2019 A1
20190076167 Fantuzzi et al. Mar 2019 A1
20190083690 Siess et al. Mar 2019 A1
20190101130 Bredenbreuker et al. Apr 2019 A1
20190117865 Walters et al. Apr 2019 A1
20190134287 Demou May 2019 A1
20190143018 Salahieh et al. May 2019 A1
20190143019 Mehaffey et al. May 2019 A1
20190170153 Scheckel Jun 2019 A1
20190175802 Tuval et al. Jun 2019 A1
20190175803 Pfeffer et al. Jun 2019 A1
20190175805 Tuval et al. Jun 2019 A1
20190175806 Tuval et al. Jun 2019 A1
20190209753 Tuval et al. Jul 2019 A1
20190209755 Nix et al. Jul 2019 A1
20190209757 Tuval et al. Jul 2019 A1
20190209758 Tuval et al. Jul 2019 A1
20190211836 Schumacher et al. Jul 2019 A1
20190216994 Pfeffer et al. Jul 2019 A1
20190224391 Liebing Jul 2019 A1
20190224392 Pfeffer et al. Jul 2019 A1
20190224393 Pfeffer et al. Jul 2019 A1
20190239998 Tuval et al. Aug 2019 A1
20190262518 Molteni et al. Aug 2019 A1
20190269840 Tuval et al. Sep 2019 A1
20190282741 Franano et al. Sep 2019 A1
20190290817 Guo et al. Sep 2019 A1
20190307561 Gosal et al. Oct 2019 A1
20190316591 Toellner Oct 2019 A1
20190321527 King et al. Oct 2019 A1
20190321530 Cambronne et al. Oct 2019 A1
20190321531 Cambronne et al. Oct 2019 A1
20190328948 Salahieh et al. Oct 2019 A1
20190336664 Liebing Nov 2019 A1
20190344001 Salahieh et al. Nov 2019 A1
20190351118 Graichen et al. Nov 2019 A1
20200038567 Siess et al. Feb 2020 A1
20200078506 Schwammenthal et al. Mar 2020 A1
20200093973 Gandhi et al. Mar 2020 A1
20200197585 Scheckel et al. Jun 2020 A1
20200237981 Tuval et al. Jul 2020 A1
20200237982 Tuval et al. Jul 2020 A1
20200237984 Tuval et al. Jul 2020 A1
20200237985 Tuval et al. Jul 2020 A1
20200246527 Hildebrand et al. Aug 2020 A1
20200288988 Goldvasser Sep 2020 A1
20210023285 Brandt Jan 2021 A1
20210069395 Tuval et al. Mar 2021 A1
20210170081 Kanz Jun 2021 A1
20210236797 D'Ambrosio et al. Aug 2021 A1
20220184376 Tuval et al. Jun 2022 A1
20220226632 Tuval et al. Jul 2022 A1
Foreign Referenced Citations (146)
Number Date Country
2013205145 May 2013 AU
2701809 Apr 2009 CA
2927346 Apr 2009 CA
1033690 Jul 1958 DE
10336902 Aug 2004 DE
0916359 May 1999 EP
1339443 Sep 2003 EP
1651290 May 2006 EP
1827531 Sep 2007 EP
1871441 Jan 2008 EP
2047872 Apr 2009 EP
2047873 Apr 2009 EP
2217300 Aug 2010 EP
2218469 Aug 2010 EP
2234658 Oct 2010 EP
2282070 Feb 2011 EP
2298374 Mar 2011 EP
2299119 Mar 2011 EP
2301598 Mar 2011 EP
2308524 Apr 2011 EP
2314331 Apr 2011 EP
2345440 Jul 2011 EP
2366412 Sep 2011 EP
2376788 Oct 2011 EP
2408489 Jan 2012 EP
2424587 Mar 2012 EP
2475415 Jul 2012 EP
2607712 Jun 2013 EP
2040639 Feb 2014 EP
2662099 Sep 2014 EP
2427230 Dec 2014 EP
2396050 Jan 2015 EP
2835141 Feb 2015 EP
2840954 Mar 2015 EP
2841122 Mar 2015 EP
2841124 Mar 2015 EP
2860849 Apr 2015 EP
2868331 May 2015 EP
2868332 May 2015 EP
2999496 Mar 2016 EP
3000492 Mar 2016 EP
3000493 Mar 2016 EP
3055922 Aug 2016 EP
3062730 Sep 2016 EP
3115070 Jan 2017 EP
3127562 Feb 2017 EP
3216467 Sep 2017 EP
3222302 Sep 2017 EP
3236079 Oct 2017 EP
3287154 Feb 2018 EP
3587155 Feb 2018 EP
3326567 May 2018 EP
3329951 Jun 2018 EP
3338825 Jun 2018 EP
3205360 Aug 2018 EP
3359214 Aug 2018 EP
3359215 Aug 2018 EP
3398624 Nov 2018 EP
3398625 Nov 2018 EP
3407930 Dec 2018 EP
3446729 Feb 2019 EP
3446730 Feb 2019 EP
3545983 Oct 2019 EP
3606575 Feb 2020 EP
3737436 Nov 2020 EP
3897814 Oct 2021 EP
2451161 Jan 2009 GB
2504175 Jan 2014 GB
2003504091 Feb 2003 JP
2012505038 Mar 2012 JP
2016509950 Apr 2016 JP
9001972 Mar 1990 WO
9013321 Nov 1990 WO
199401148 Jan 1994 WO
9934847 Jul 1999 WO
2001083016 May 2000 WO
2000043053 Jul 2000 WO
0062838 Oct 2000 WO
2002070039 Mar 2001 WO
2002038085 May 2002 WO
03006096 Jan 2003 WO
03103745 Dec 2003 WO
03103745 Dec 2003 WO
2004073796 Sep 2004 WO
2005020848 Mar 2005 WO
2007081818 Jul 2007 WO
2007112033 Oct 2007 WO
2007127477 Nov 2007 WO
2008005747 Jan 2008 WO
2008005990 Jan 2008 WO
2008055301 May 2008 WO
2008104858 Sep 2008 WO
2009010963 Jan 2009 WO
2009046096 Apr 2009 WO
2009129481 Oct 2009 WO
2010042546 Apr 2010 WO
2010063494 Jun 2010 WO
2010127871 Nov 2010 WO
2010133567 Nov 2010 WO
2010150208 Dec 2010 WO
2011035926 Mar 2011 WO
2011047884 Apr 2011 WO
2011076441 Jun 2011 WO
2011089022 Jul 2011 WO
2012007141 Jan 2012 WO
2013032849 Mar 2013 WO
2013070186 May 2013 WO
2013093001 Jun 2013 WO
2013148697 Oct 2013 WO
2013183060 Dec 2013 WO
2014141284 Sep 2014 WO
2015063277 May 2015 WO
2015160943 Oct 2015 WO
2015177793 Nov 2015 WO
2016001218 Jan 2016 WO
2016005803 Jan 2016 WO
2016185473 Nov 2016 WO
2016207293 Dec 2016 WO
2017053361 Mar 2017 WO
2017060254 Apr 2017 WO
2017081561 May 2017 WO
2017137604 Aug 2017 WO
2017147291 Aug 2017 WO
2018033920 Feb 2018 WO
2018061001 Apr 2018 WO
2018061002 Apr 2018 WO
2018067410 Apr 2018 WO
2018078615 May 2018 WO
2018096531 May 2018 WO
2018158636 Sep 2018 WO
2018172848 Sep 2018 WO
2018220589 Dec 2018 WO
2018226991 Dec 2018 WO
2018234454 Dec 2018 WO
2019094963 May 2019 WO
2019125899 Jun 2019 WO
2019138350 Jul 2019 WO
2019152875 Aug 2019 WO
2019158996 Aug 2019 WO
2019229223 Dec 2019 WO
2020152611 Jul 2020 WO
2021159147 Aug 2021 WO
2021198881 Oct 2021 WO
2021205346 Oct 2021 WO
2022189932 Sep 2022 WO
2023062453 Apr 2023 WO
Non-Patent Literature Citations (302)
Entry
U.S. Appl. No. 62/796,138, filed Jan. 24, 2019.
U.S. Appl. No. 62/851,716, filed May 23, 2019.
U.S. Appl. No. 62/870,821, filed Jul. 5, 2019.
U.S. Appl. No. 62/896,026, filed Sep. 5, 2019.
Extended European Search Report for European Application No. 19172327.9 dated Aug. 23, 2019.
International Search Report and Written Opinion from International Application No. PT/IB2019/050186 dated Jul. 18, 2019.
Rodefeld, “Cavopulmonary assist for the univentricular Fontan circulation: von Karman viscous impeller pump”, The Journal of Thoracic and Cardiovascular Surgery, vol. 140, No. 3, 2010, pp. 529-536.
Sianos, et al., “The Recover® LP 2.5 catheter-mounted left ventricular assist device”, EuroIntervention, EuroPCROnline.com, 2006, pp. 116-119.
Throckmorton, et al., “Mechanical Cavopulmonary Assist for the Univentricular Fontan Circulation Using a Novel Folding Propeller Blood Pump”, ASAIO Journal, 2007, pp. 734-741.
Extended European Search Report for European Application No. 20159714.3 dated Jul. 3, 2020.
Extended European Search Report for European Application No. 20159716.8 dated Jul. 3, 2020.
Extended European Search Report for European Application No. 20159718.4 dated Jul. 9, 2020.
Invitation to Pay Additional Fees for International Application No. PCT/IB2020/050515 dated Mar. 31, 2020.
Non-Final Office Action for U.S. Appl. No. 16/281,237 dated Aug. 21, 2020.
Restriction Requirement for U.S. Appl. No. 16/279,352 dated Aug. 11, 2020.
Restriction Requirement for U.S. Appl. No. 16/280,566 dated Aug. 11, 2020.
US 9,427,507, 07/2004, Abiomed Europe GMBH (withdrawn)
US 9,399,088, 04/2013, Abiomed Europe GMBH (withdrawn)
International Search Report and Written Opinion from International Application No. PCT/IL2017/051158 dated Jan. 17, 2018.
U.S. Appl. No. 14/567,439, filed Dec. 11, 2014.
U.S. Appl. No. 16/276,965, filed Feb. 15, 2019.
U.S. Appl. No. 16/277,411, filed Feb. 15, 2019.
U.S. Appl. No. 16/278,482, filed Feb. 18, 2019.
U.S. Appl. No. 16/279,352, filed Feb. 19, 2019.
U.S. Appl. No. 16/280,566, filed Feb. 20, 2019.
U.S. Appl. No. 16/281,237, filed Feb. 21, 2019.
U.S. Appl. No. 16/281,264, filed Feb. 21, 2019.
U.S. Appl. No. 61/656,244, filed Jun. 6, 2012.
U.S. Appl. No. 61/779,803, filed Mar. 13, 2013.
U.S. Appl. No. 61/914,470, filed Dec. 11, 2013.
U.S. Appl. No. 61/914,475, filed Dec. 11, 2013.
U.S. Appl. No. 62/000,192, filed May 19, 2014.
U.S. Appl. No. 62/162,881, filed May 18, 2015.
U.S. Appl. No. 62/401,403, filed Sep. 29, 2016.
U.S. Appl. No. 62/412,631, filed Oct. 25, 2016.
U.S. Appl. No. 62/425,814, filed Nov. 23, 2016.
U.S. Appl. No. 62/543,540, filed Aug. 10, 2017.
U.S. Appl. No. 62/615,538, filed Jan. 10, 2018.
U.S. Appl. No. 62/665,718, filed May 2, 2018.
U.S. Appl. No. 62/681,868, filed Jun. 7, 2018.
U.S. Appl. No. 62/727,605, filed Sep. 6, 2018.
“Tanslation of decision of Board 4 (Nullity Board) of the German Federal Patent Court re German patent 10336902”, pronounced Nov. 15, 2016, and appendices to decision, 62 pages.
Agarwal, et al., “Newer-generation ventricular assist devices.”, Best Practice & Research Clinical Anaesthesiology, 26.2, 2012, pp. 117-130.
Alba, et al., “The future is here: ventricular assist devices for the failing heart”, Expert review of cardiovascular therapy, 7.9, 2009, pp. 1067-1077.
Burnett, et al., “Renal Interstitial Pressure and Sodium Excretion During Renal Vein Constriction”, American Physiological Society, 1980, pp. F279-F282.
Cassidy, et al., “The Conductance Volume Catheter Technique for Measurement of Left Ventricular Volume in Young Piglets”, Pediatric Research, Val. 31, No. 1, 1992, pp. 85-90.
Coxworth, “Artificial Vein Valve Could Replace Drugs For Treating Common Circulatory Problem”, Published on Gizmag website (http://www.gizmag.com/artificial-venous-valve-cvi/21785/), Mar. 9, 2012.
Damman, et al., “Decreased Cardiac Output, Venous Congestion and the Association With Renal Impairment In Patients With Cardiac Dysfunction”, European Journal of Heart Failure, vol. 9, 2007, pp. 872-878.
Damman, et al., “Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease”, Journal of American College of Cardiology, vol. 53, 2009, pp. 582-588.
Doty, et al., “The Effect of Increased Renal Venous Pressure on Renal Function”, The Journal of Trauma,, vol. 47(6), Dec. 1999, pp. 1000-1003.
Felker, et al., “Anemia as a Risk Factor and Therapeutic Target In Heart Failure”, Journal of the American College of Cardiology, vol. 44, 2004, pp. 959-966.
Firth, et al., “Raised Venous Pressure: A Direct Cause of Sodium Retention in Oedema?”, The Lancet, May 7, 1988, pp. 1033-1036.
Forman, et al., “Incidence, Predictors at Admission, and Impact of Worsening Renal Function Among Patients Hospitalized With Heart Failure”, Journal of American College of Cardiology, vol. 43, 2004, pp. 61-67.
Fraser, et al., “The use of computational fluid dynamics in the development of ventricular assist devices”, Medical engineering & physics, 33.3, 2011, pp. 263-280.
Frazier, et al., “First Human Use of the Hemopump, a CatheterMounted Ventricular Assist Device”, Ann Thorac Surg, 49, 1990, pp. 299-304.
Gomes, et al., “Heterologous Valve Implantation In The Infra-Renal Vena Cava For Treatment of the Iliac Venous Valve Regurgitation Disease: Experimental Study”, Rev Bras Cir Cardiovasc, vol. 17(4), 2002, pp. 367-369.
Haddy, et al., “Effect of Elevation of Intraluminal Pressure on Renal Vascular Resistance”, Circulation Research Journal of the American Heart Association, vol. 4, 1956, pp. 659-663.
Heywood, et al., “High Prevalence of Renal Dysfunction and its Impact on Outcome in 118,465 Patients Hospitalized With Acute Decompensated Heart Failure: A Report From the ADHERE Database”, Journal of Cardiac Failure, vol. 13, 2007, pp. 422-430.
Hillege, et al., “Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure”, Circulation Journal of the American Heart Association, vol. 113, 2006, pp. 671-678.
Hillege, et al., “Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure”, Circulation Journal of the American Heart Association, vol. 102, 2000, pp. 203-210.
Hsu, et al., “Review of recent patents on foldable ventricular assist devices”, Recent Patents on Biomedical Engineering, 5.3, 2012, pp. 208-222.
Ikari, “The Physics of Guiding Catheter; The IKARI Guiding Catheter in TRI”, available at httu:i /www.docstoc.com/docs/148136553/The-[KARI-catheter—anovel-guide-for-TRI—, uploaded on Mar. 8, 2013.
Kafagy, et al., “Design of axial blood pumps for patients with dysfunctional fontan physiology: computational studies and performance testing”, Artificial organs, 39.1, 2015, pp. 34-42.
Kang, et al., “Fluid dynamics aspects of miniaturized axial-flow blood pump”, Bio-medical materials and engineering, 24.1, 2014, pp. 723-729.
Koochaki, et al., “A new design and computational fluid dynamics study of an implantable axial blood pump”, Australasian Physical & Engineering Sciences in Medicine, 36.4, 2013, pp. 417-422.
Lauten, et al., “Heterotopic Transcatheter Tricuspid Valve Implantation: First-In-Man Application of a Novel Approach To Tricuspid Regurgitation”, European Heart Journal, (1-7 as printed), Feb. 15, 2011, pp. 1207-1213.
McAlister, et al., “Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study”, Circulation Journal of the American Heart Association, 109, 2004, pp. 1004-1009.
Meyns, et al., “The Heart-Hemopump Interaction: A Study of Hemopump Flow as a Function of Cardiac Activity”, Artificial Organs, Vot. 20, No. 6, 1996, pp. 641-649.
Mullens, et al., “Elevated Intra-Abdominal Pressure in Acute Decompensated Heart Failure. A Potential Contributor to Worsening Renal Function”, Journal of the American College of Cardiology, vol. 51, 2008, pp. 300-306.
Mullens, et al., “Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure”, Journal of American College of Cardiology, vol. 53, 2009, pp. 589-596.
Mullens, et al., “Prompt Reduction in Intra-Abdominal Pressure Following Large-Volume Mechanical Fluid Removal Improves Renal Insufficiency in Refractory Decompensated Heart Failure”, Journal of Cardiac Failure, vol. 14, 2008, pp. 508-514.
Notarius, et al., “Central Venous Pressure During Exercise: Role of Muscle Pump”, Canadian Journal of Physiology and Pharmacology, vol. 74(6), 1996, pp. 647-651.
Park, et al., “Nutcracker Syndrome: Intravascular Stenting Approach”, Nephrol Dial Transplant, vol. 15, 2000, pp. 99-101.
Reul, et al., “Blood pumps for circulatory support”, Perfusion-Sevenoaks, 15.4, 2000, pp. 295-312.
Reul, et al., “Rotary blood pumps in circulatory assist”, Perfusion, 10(3), May 1995, pp. 153-158.
Schmitz-Rode, et al., “An Expandable Percutaneous Catheter Pump for Left Ventricular Support”, Journal of the American College of Cardiology, vol. 45, 2005, pp. 1856-1861.
Schmitz-Rode, et al., “Axial flow catheter pump for circulatory support”, Biomed Tech (Berl), 47 Suppl 1 Pt 1, 2002, pp. 142-143.
Semple, et al., “Effect of Increased Renal Venous Pressure on Circulatory “Autoregulation” of Isolated Dog Kidneys”, Circulation Research Journal of The American Heart Association, vol. 7, 1959, pp. 643-648.
Siess, et al., “Concept, realization, and first in vitro testing of an intraarterial microaxial blood pump”, Artificial Organs, vol. 15, No. 7, 1995, pp. 644-652.
Siess, et al., “Hemodynamic system analysis of intraarterial microaxial pumps in vitro and in vivo”, Artificial Organs, vol. 20, No. 6, Jun. 1996, pp. 650-661.
Siess, , “PhD Chapter 3—English translation”, (citation info here: https://www.shaker.eu/en/content/catalogue/index.asp?lang=en&ID=8&ISBN=978-3-8265-6150-4&search=yes ).
Song, et al., “Axial flow blood pumps”, ASAIO journal, 49, 2003, pp. 355-364.
Tang, et al., “Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options”, Circulation Journal of the American Heart Association, vol. 113, 2006, pp. 2454-2461.
Throckmorton, et al., “Design of a protective cage for an intra vascular axial flow blood pump to mechanically assist the failing Fontan”, Artificial organs, 33.8, 2009, pp. 611-621.
Thunberg, et al., “Ventricular assist devices today and tomorrow”, Journal of cardiothoracic and vascular anesthesia, 24.4, 2010, pp. 656-680.
Timms, , “A review of clinical ventricular assist devices”, Medical engineering & physics, 33.9, 2011, pp. 1041-1047.
Triep, et al., “Computational Fluid Dynamics and Digital Particle Image Velocimetry Study of the Flow Through an Optimized Micro-axial Blood Pump”, Artificial Organs, vol. 30, No. 5, May 2006, pp. 384-391.
Uthoff, et al., “Central venous pressure at emergency room presentation predicts cardiac rehospitalization in patients with decompensated heart failure”, European Journal of Heart Failure, 12, 2010, pp. 469-476.
Van Mieghem, et al., “Design and Principle of Operation of the HeartMate PHPTM (Percutaneous Heart Pump)”, EuroIntervention, Jaa-035 2016, doi: 10.4244/ EIJ-D-15-00467, 2016.
Vercaemst, et al., “Impella: A Miniaturized Cardiac Support System in an Era of Minimal Invasive Cardiac Surgery”, Presented at the 39th International Conference of the American Society of Extra-Corporeal Technology, Miami, Florida, Mar. 22-25, 2001.
Wampler, , “The first co-axial flow pump for human use: the Hemopump”, Flameng W. (eds) Temporary Cardiac Assist with an Axial Pump System, 1991.
Wencker, , “Acute Cardio-Renal Syndrome: Progression From Congestive Heart Failure to Congestive Kidney Failure”, Current Heart Failure Reports, vol. 4, 2007, pp. 134-138.
Winton, “The Control of Glomerular Pressure by Vascular Changes Within the Mammalian Kidney, Demonstrated by the Actions of Adrenaline”, Journal of Physiology, vol. 73, Nov. 1931, pp. 151-162.
Winton, “The Influence of Venous Pressure on the Isolated Mammalian Kidney”, Journal of Physiology, vol. 72(1), Jun. 6, 1931, pp. 49-61.
Wood, “The Mechanism of the Increased Venous Pressure With Exercise in Congestive Heart Failure”, Journal of Clinical Investigation, vol. 41(11), 1962, pp. 2020-2024.
Wu, et al., “Design and simulation of axial flow maglev blood pump”, International Journal of Information Engineering and Electronic Business, 3.2, 2011, p. 42.
Yancy, et al., “Clinical Presentation, Management, and in-Hospital Outcomes of Patients Admitted With Acute Decompensated Heart Failure With Preserved Systolic Function. A Report From the Acute Decompensated Heart Failure National Registry (ADHERE) Database”, Journal of the American College of Cardiology, vol. 47(1), 2006, pp. 76-84.
Non-Final Office Action for U.S. Appl. No. 16/276,965 dated Jun. 19, 2020.
Non-Final Office Action for U.S. Appl. No. 16/278,482 dated Jun. 23, 2020.
Non-Final Office Action for U.S. Appl. No. 16/281,264 dated Jun. 29, 2020.
U.S. Appl. No. 16/750,354, filed Jan. 23, 2020.
International Search Report and Written Opinion from International Application No. PCT/IB2020/050515 dated Sep. 9, 2020.
Invitation to Pay Additional Fees in International Application No. PCT/IB2020/050515 dated Mar. 31, 2020.
Non-Final Office Action for U.S. Appl. No. 16/279,352 dated Nov. 10, 2020.
Non-Final Office Action for U.S. Appl. No. 16/276,965 dated Nov. 30, 2020.
Notice of Allowance for U.S. Appl. No. 16/278,482 dated Dec. 2, 2020.
Notice of Allowance for U.S. Appl. No. 16/281,264 dated Nov. 12, 2020.
U.S. Appl. No. 16/952,327, filed Nov. 19, 2020.
U.S. Appl. No. 16/952,389, filed Nov. 19, 2020.
U.S. Appl. No. 16/952,444, filed Nov. 19, 2020.
U.S. Appl. No. 17/069,064, filed Oct. 13, 2020.
U.S. Appl. No. 17/069,321, filed Oct. 13, 2020.
U.S. Appl. No. 17/069,570, filed Oct. 13, 2020.
U.S. Appl. No. 17/070,323, filed Oct. 14, 2020.
U.S. Appl. No. 17/070,670, filed Oct. 14, 2020.
U.S. Appl. No. 17/077,769, filed Oct. 22, 2020.
U.S. Appl. No. 17/078,439, filed Oct. 23, 2020.
U.S. Appl. No. 17/078,472, filed Oct. 23, 2020.
Corrected Notice of Allowability for U.S. Appl. No. 16/281,237 dated Mar. 31, 2021.
Extended Search Report for European Application No. 20195082.1 dated Nov. 5, 2020.
Extended Search Report for European Application No. 20195084.7 dated Nov. 5, 2020.
Extended Search Report for European Application No. 20195085.4 dated Nov. 4, 2020.
Extended Search Report for European Application No. 20195987.1 dated Nov. 5, 2020.
Issue Notification for U.S. Appl. No. 16/278,482 dated Jan. 13, 2021.
Issue Notification for U.S. Appl. No. 16/281,264 dated Dec. 16, 2020.
Non-Final Office Action for U.S. Appl. No. 16/277,411 dated Feb. 9, 2021.
Non-Final Office Action for U.S. Appl. No. 16/280,566 dated Dec. 21, 2020.
Notice of Allowance for U.S. Appl. No. 16/281,237 dated Feb. 1, 2021.
Supplemental Notice of Allowability for U.S. Appl. No. 16/278,482 dated Dec. 24, 2020.
U.S. Appl. No. 17/176,344, filed Feb. 16, 2021.
U.S. Appl. No. 17/177,296, filed Feb. 17, 2021.
U.S. Appl. No. 17/180,041, filed Feb. 19, 2021.
U.S. Appl. No. 17/182,482, filed Feb. 23, 2021.
Extended Search Report for European Application No. 21158196.2 dated Apr. 8, 2021.
Extended Search Report for European Application No. 21158903.1 dated Apr. 9, 2021.
Final Office Action for U.S. Appl. No. 16/276,965 dated Apr. 13, 2021.
Final Office Action for U.S. Appl. No. 16/277,411 dated Jun. 21, 2021.
Final Office Action for U.S. Appl. No. 16/279,352 dated May 3, 2021.
Issue Notification for U.S. Appl. No. 16/281,237 dated Apr. 14, 2021.
Non-Final Office Action for U.S. Appl. No. 16/276,965 dated Jul. 26, 2021.
Notice of Allowance for U.S. Appl. No. 16/280,566 dated Aug. 31, 2021.
Corrected Notice of Allowability for U.S. Appl. No. 16/279,352 dated Nov. 3, 2021.
Examination Report for Indian Patent Application No. 201917018651 dated Jun. 30, 2021.
Extended Search Report for European Application No. 21156647.6 dated May 21, 2021.
Extended Search Report for European Application No. 21158902.3 dated Apr. 29, 2021.
International Search Report and Written Opinion from International Application No. PCT/IB2021/052590 dated Sep. 14, 2021.
International Search Report and Written Opinion from International Application No. PCT/IB2021/052857 dated Oct. 5, 2021.
Invitation to Pay Additional Fees for International Application No. PCT/IB2021/052590 dated Jul. 23, 2021.
Invitation to Pay Additional Fees for International Application No. PCT/IB2021/052857 dated Jul. 7, 2021.
Issue Notification for U.S. Appl. No. 16/279,352 dated Nov. 10, 2021.
Issue Notification for U.S. Appl. No. 16/280,566 dated Nov. 10, 2021.
Issue Notification for U.S. Appl. No. 16/750,354 dated Nov. 17, 2021.
Non-Final Office Action for U.S. Appl. No. 17/069,064 dated Dec. 9, 2021.
Non-Final Office Action for U.S. Appl. No. 17/069,321 dated Nov. 18, 2021.
Notice of Allowance for U.S. Appl. No. 16/277,411 dated Dec. 8, 2021.
Notice of Allowance for U.S. Appl. No. 16/279,352 dated Oct. 1, 2021.
Notice of Allowance for U.S. Appl. No. 16/750,354 dated Oct. 18, 2021.
Office Action for Chinese Application No. 201780066201.3 dated Jun. 29, 2021.
Office Action for Japanese Patent Application No. 2019-521643 dated Sep. 28, 2021.
Supplemental Notice of Allowability for U.S. Appl. No. 16/279,352 dated Oct. 21, 2021.
U.S. Appl. No. 17/609,589, filed Nov. 8, 2021.
U.S. Appl. No. 63/006,122, filed Apr. 7, 2020.
U.S. Appl. No. 63/114,136, filed Nov. 16, 2020.
U.S. Appl. No. 63/129,983, filed Dec. 23, 2020.
Corrected Notice of Allowability for U.S. Appl. No. 16/810,172 dated Feb. 2, 2022.
Issue Notification for U.S. Appl. No. 16/276,965 dated Mar. 16, 2022.
Issue Notification for U.S. Appl. No. 16/277,411 dated Feb. 9, 2022.
Issue Notification for U.S. Appl. No. 16/810,086 dated Mar. 9, 2022.
Issue Notification for U.S. Appl. No. 16/810,172 dated Mar. 23, 2022.
Issue Notification for U.S. Appl. No. 17/069,321 dated Mar. 16, 2022.
Non-Final Office Action for U.S. Appl. No. 16/810,121 dated Mar. 9, 2022.
Non-Final Office Action for U.S. Appl. No. 17/176,344 dated Apr. 20, 2022.
Notice of Allowance for U.S. Appl. No. 16/276,965 dated Jan. 26, 2022.
Notice of Allowance for U.S. Appl. No. 16/810,086 dated Jan. 7, 2022.
Notice of Allowance for U.S. Appl. No. 16/810,172 dated Jan. 10, 2022.
Notice of Allowance for U.S. Appl. No. 16/810,270 dated Apr. 14, 2022.
Notice of Allowance for U.S. Appl. No. 17/069,321 dated Feb. 2, 2022.
Supplemental Notice of Allowability for U.S. Appl. No. 16/276,965 dated Mar. 10, 2022.
Supplemental Notice of Allowability for U.S. Appl. No. 16/276,965 dated Mar. 2, 2022.
U.S. Appl. No. 16/810,086, filed Mar. 5, 2020.
U.S. Appl. No. 16/810,121, filed Mar. 5, 2020.
U.S. Appl. No. 17/574,701, filed Jan. 13, 2022.
U.S. Appl. No. 17/677,571, filed Feb. 22, 2022.
U.S. Appl. No. 17/678,122, filed Feb. 23, 2022.
Corrected Notice of Allowability for U.S. Appl. No. 16/810,121 dated Jun. 28, 2022.
Examination Report for Australian Patent Application No. 2017349920 dated Jun. 2, 2022.
Examination Report for Indian Patent Application No. 202047017397 dated May 4, 2022.
Extended European Search Report for EP Patent Application No. 22163640.0 dated Jun. 29, 2022.
Extended European Search Report for European Application No. 21208803.3 dated Apr. 13, 2022.
Extended European Search Report for European Application No. 21209256.3 dated Mar. 2, 2022.
Final Office Action for U.S. Appl. No. 17/069,064 dated May 25, 2022.
Notice of Allowance for U.S. Appl. No. 16/810,121 dated Jun. 1, 2022.
Notice of Allowance for U.S. Appl. No. 16/810,270 dated Jul. 22, 2022.
Restriction Requirement for U.S. Appl. No. 16/810,116 dated Jun. 29, 2022.
U.S. Appl. No. 17/528,015, filed Nov. 16, 2021.
U.S. Appl. No. 17/528,807, filed Nov. 17, 2021.
U.S. Appl. No. 17/532,318, filed Nov. 22, 2021.
U.S. Appl. No. 17/857,402, filed Jul. 5, 2022.
Corrected Notice of Allowability for U.S. Appl. No. 16/810,116 dated Apr. 7, 2023.
Notice of Allowance for U.S. Appl. No. 16/810, 116 dated Mar. 13, 2023.
Notice of Allowance for U.S. Appl. No. 17/069,604 dated Mar. 8, 2023.
U.S. Appl. No. 18/121,995, filed Mar. 15, 2023.
U.S. Appl. No. 18/122,456, filed Mar. 16, 2023.
U.S. Appl. No. 18/122,486, filed Mar. 16, 2023.
U.S. Appl. No. 18/122,504, filed Mar. 16, 2023.
Wampler , “U.S. News & World Report”, Captain Hemo, pp. 1-2, May 16, 1988.
Corrected Notice of Allowability for U.S. Appl. No. 17/182,482 dated Feb. 7, 2023.
Corrected Notice of Allowability for U.S. Appl. No. 16/810,121 mailed Sep. 20, 2022.
Examination Report for Australian Patent Application No. 2017349920 dated Nov. 4, 2022.
Extended European Search Report for European Application No. 22155936.2 dated Jul. 8, 2022.
Extended European Search Report for European Application No. 22163648.3 dated Aug. 10, 2022.
Extended European Search Report for European Application No. 22163653.3 dated Jul. 1, 2022.
Final Office Action for U.S. Appl. No. 17/176,344 dated Oct. 12, 2022.
International Search Report and Written Opinion from International Application No. PCT/IB2022/051990 dated Aug. 10, 2022.
Invitation to Pay Additional Fees for International Application No. PCT/IB2022/051990 dated May 13, 2022.
Issue Notification for U.S. Appl. No. 16/810,270 dated Oct. 12, 2022.
Non-Final Office Action for U.S. Appl. No. 16/952,327 dated Nov. 8, 2022.
Non-Final Office Action for U.S. Appl. No. 16/952,389 dated Dec. 21, 2022.
Non-Final Office Action for U.S. Appl. No. 16/952,444 dated Jan. 6, 2023.
Non-Final Office Action for U.S. Appl. No. 17/069,064 dated Nov. 7, 2022.
Non-Final Office Action for U.S. Appl. No. 17/069,570 dated Oct. 6, 2022.
Non-Final Office Action for U.S. Appl. No. 17/070,323 dated Oct. 6, 2022.
Non-Final Office Action for U.S. Appl. No. 17/070,670 dated Oct. 5, 2022.
Non-Final Office Action for U.S. Appl. No. 17/077,769 dated Oct. 5, 2022.
Non-Final Office Action for U.S. Appl. No. 17/180,041 dated Jan. 31, 2023.
Notice of Allowance for U.S. Appl. No. 16/810,121 dated Aug. 19, 2022.
Notice of Allowance for U.S. Appl. No. 17/182,482 dated Jan. 5, 2023.
Office Action for Japanese Application No. 2019-521643 dated May 22, 2022.
Office Action for Japanese Application No. 2019-521643 dated Oct. 27, 2022.
Third Party Submission received during the prosecution of U.S. Appl. No. 17/078,439 dated Sep. 28, 2022.
U.S. Appl. No. 63/003,955, filed Apr. 2, 2020.
U.S. Appl. No. 63/158,708, filed Mar. 9, 2021.
U.S. Appl. No. 63/254,321, filed Oct. 11, 2021.
“Compendium of Technical and Scientific Information for the Hemopump Temporary Cardiac Assist System”, Johnson & Johnson Interventional Systems, 1988, pp. 1-15.
Achour , et al., “Mechanical Left Ventricular Unloading Prior to Reperfusion Reduces Infarct Size in a Canine Infarction Model”, Catheterization and Cardiovascular Interventions 64, 2005, pp. 182-192.
Butler , et al., “The Hemopump—A New Cardiac Prothesis Device”, Reprinted from IEEE Transactions on Biomedical Engineering, vol. 37, No. 2, Feb. 1990, pp. 192-195.
Chan , et al., “Rapid manufacturing techniques in the development of an axial blood pump impeller”, Proc. Instn Mech. Engrs vol. 217 Part H: J. Engineering in Medicine, 2003, pp. 469-475.
Dekker , et al., “Efficacy of a New Intraaortic Propeller Pump vs the Intraaortic Balloon Pump”, Chest, vol. 123, Issue 6, Jun. 2003, pp. 2089-2095.
Flameng , “Temporary Cardiac Assist with an Axial Pump System”, Steinkopff Verlag Darmstadt, 1991, 79 pages.
Frazier , et al., “Treatment of Cardiac Allograft Failure by use of an IntraAortic Axial Flow Pump”, Journal of Heart Transplantation, St. Louis, vol. 9, No. 4, pp. 408-414, Jul. 1990.
Gunther , et al., “Experimentelle Radiologie”, Life Sciences, Berichte Aus Der Rheinischwestfälischen Technischen Hochschule Aachen Ausgabe Feb. 2002, 9 pages.
Ledoux , et al., “Left Ventricular Unloading With Intra-aortic Counter Pulsation Prior to Reperfusion Reduces Myocardial Release of Endothelin-1 and Decreases Infarction Size in a Porcine Ischemia-Reperfusion Model”, Catheterization and Cardiovascular Interventions 72, 2008, pp. 513-521.
Merhige , et al., “Effect of the Hemopump Left Ventricular Assist Device on Regional Myocardial Perfusion and Function”, Reduction of Ischemia during Coronary Occlusion, Johnson & Johnson Interventional Systems Supplement 3, Circulation vol. 80, No. 5, Nov. 1989, pp. III-159-III-166.
Roundtree , et al., “The Hemopump Cardiac Assist System: Nursing Care of the Patient”, Reprinted from Critical Care Nurse, Apr. 1991.
Scholz , et al., “MechanicaL left Ventricular Unloading During High Risk Coronary Angioplasty: First Use of a New Percutaneous Transvalvular Left Ventricular Assist Device”, Catheterization and Cardiovascular Diagnosis 31, 1994, pp. 61-69.
Siess , “System Analysis and Development of Intravascular Rotation Pumps for Cardiac Assist”, Helmholtz-Institute—Chapter 3, Jun. 1998, 17 pages.
Smalling , et al., “Improved Regional Myocardial Blood Flow, Left Ventricular Unloading, and Infarct Salvage Using an Axial-Flow, Transvalvular Left Ventricular Assist Device”, A Comparison With Intra-Aortic Balloon Counterpulsation and Reperfusion Alone in a Canine Infarction Model, Presented in part at the American College of Cardiology 38th Annual Scientific Session, Mar. 1990, pp. 1152-1160.
Smalling , et al., “The Hemopump: A transvalvular, axial flow, left ventricular assist device”, Coronary Artery Disease, Circulatory support devices in clinical cardiology, vol. 2 No. 6, pp. 666-671, Aug. 1991.
Smalling , et al., “Transvalvular Left Ventricular Assistance in Cardiogenic Shock Secondary to Acute Myocardial Infarction”, Evidence for Recovery From Near Fatal Myocardial Stunning, JACC vol. 23, No. 3, pp. 637-644, Mar. 1, 1994.
Tamareille , et al., “Left ventricular unloading before reperfusion reduces endothelin-1 release and calcium overload in porcine myocardial infarction”, Cardiopulmonary Support and Physiology, The Journal of Thoracic and Cardiovascular Surgery, vol. 136, No. 2, 2008, pp. 343-351.
Wampler , “Newspaper Articles”, Captain Hemo, 1988, 6 pages.
Wampler , “Newsweek”, Captain Hemo, May 16, 1988, 3 pages.
Wampler , “THI Today”, Captain Hemo, Summer 1988, 2 pages.
Wampler , “Time Magazine”, Captain Hemo, May 1988, 2 pages.
Wampler , et al., “Treatment of Cardiogenic Shock With the Hemopump Left Ventricular Assist Device”, Annual of Thoracic Surgery, vol. 52, pp. 560-513, 1991.
Corrected Notice of Allowability for U.S. Appl. No. 17/070,323 dated Jun. 1, 2023.
Corrected Notice of Allowability for U.S. Appl. No. 17/180,041 dated Jun. 30, 2023.
Examination Report for Indian Patent Application No. 202147033522 dated May 24, 2023.
Extended Search Report and Preliminary Opinion for European Application No. 23159720.4 dated Jun. 27, 2023.
Extended Search Report for European Application No. 22197511.3 dated Dec. 5, 2022.
Extended Search Report for European Application No. 23159721.2 dated Jun. 26, 2023.
Extended Search Report for European Application No. 23159724.6 dated Jun. 26, 2023.
Extended Search Report for European Application No. 23159725.3 dated Jun. 28, 2023.
Final Office Action for U.S. Appl. No. 16/952,327 dated Jun. 8, 2023.
Final Office Action for U.S. Appl. No. 16/952,389 dated Jul. 18, 2023.
Final Office Action for U.S. Appl. No. 16/952,444 dated Jul. 5, 2023.
Final Office Action for U.S. Appl. No. 17/069,570 dated Apr. 28, 2023.
Final Office Action for U.S. Appl. No. 17/070,670 dated Jun. 2, 2023.
Final Office Action for U.S. Appl. No. 17/077,769 dated Jun. 7, 2023.
International Search Report and Written Opinion from International Application No. PCT/IB2022/058101 dated Feb. 20, 2023.
Issue Notification for U.S. Appl. No. 16/810,116 dated May 17, 2023.
Non-Final Office Action for U.S. Appl. No. 17/078,439 dated Jun. 1, 2023.
Non-Final Office Action for U.S. Appl. No. 17/078,472 dated May 4, 2023.
Notice of Allowance for U.S. Appl. No. 17/070,323 dated Aug. 30, 2023.
Notice of Allowance for U.S. Appl. No. 17/070,323 dated May 15, 2023.
Notice of Allowance for U.S. Appl. No. 17/173,944 dated Jul. 10, 2023.
Notice of Allowance for U.S. Appl. No. 17/180,041 dated Jun. 13, 2023.
Notice of Allowance for U.S. Appl. No. 17/180,041 dated Sep. 18, 2023.
Notice of Allowance for U.S. Appl. No. 17/182,482 dated Apr. 21, 2023.
Office Action for Canadian Application No. 3,039,285 dated Mar. 24, 2023.
Office Action for Canadian Application No. 3,122,415 dated Mar. 31, 2023.
Office Action for Chinese Application No. 201980007116.9 dated Nov. 28, 2022.
Office Action for Japanese Application No. 2019-521643 dated Apr. 11, 2023.
Office Action for Japanese Application No. 2020-537746 dated Feb. 21, 2023.
U.S. Appl. No. 18/447,025, filed Aug. 9, 2023.
U.S. Appl. No. 18/447,050, filed Aug. 9, 2023.
U.S. Appl. No. 18/447,064, filed Aug. 9, 2023.
U.S. Appl. No. 18/447,074, filed Aug. 9, 2023.
U.S. Appl. No. 18/447,086, filed Aug. 9, 2023.
U.S. Appl. No. 63/317,199, filed Mar. 7, 2022.
Corrected Notice of Allowance for U.S. Appl. No. 17/070,323 dated Oct. 4, 2023.
Corrected Notice of Allowance for U.S. Appl. No. 17/077,769 dated Oct. 4, 2023.
Corrected Notice of Allowance for U.S. Appl. No. 17/180,041 dated Oct. 4, 2023.
Final Office Action for U.S. Appl. No. 17/078,472 dated Oct. 23, 2023.
Issue Notification for U.S. Appl. No. 17/070,323 dated Oct. 18, 2023.
Issue Notification for U.S. Appl. No. 17/180,041 dated Oct. 18, 2023.
Non-Final Office Action for U.S. Appl. No. 16/952,327 dated Oct. 13, 2023.
Non-Final Office Action for U.S. Appl. No. 17/069,570 dated Oct. 2, 2023.
Non-Final Office Action for U.S. Appl. No. 17/574,701 dated Sep. 27, 2023.
Notice of Allowance for U.S. Appl. No. 17/077,769 dated Sep. 27, 2023.
Office Action for Canadian Application No. 3,080,800 dated Sep. 12, 2023.
Examination Report for Australian Application No. 2019206421 dated Sep. 29, 2023.
Related Publications (1)
Number Date Country
20190175802 A1 Jun 2019 US
Provisional Applications (2)
Number Date Country
62543540 Aug 2017 US
62412631 Oct 2016 US
Continuations (1)
Number Date Country
Parent PCT/IL2017/051158 Oct 2017 US
Child 16275559 US